US20200360167A1 - Pyloric anchors and methods for intestinal bypass sleeves - Google Patents
Pyloric anchors and methods for intestinal bypass sleeves Download PDFInfo
- Publication number
- US20200360167A1 US20200360167A1 US16/983,530 US202016983530A US2020360167A1 US 20200360167 A1 US20200360167 A1 US 20200360167A1 US 202016983530 A US202016983530 A US 202016983530A US 2020360167 A1 US2020360167 A1 US 2020360167A1
- Authority
- US
- United States
- Prior art keywords
- wall
- proximal
- distal
- structural element
- anchor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000000968 intestinal effect Effects 0.000 title description 16
- 238000000034 method Methods 0.000 title description 9
- 210000001187 pylorus Anatomy 0.000 claims abstract description 69
- 230000002496 gastric effect Effects 0.000 claims abstract description 43
- 239000007943 implant Substances 0.000 claims description 90
- 210000001198 duodenum Anatomy 0.000 claims description 25
- 230000006835 compression Effects 0.000 claims description 14
- 238000007906 compression Methods 0.000 claims description 14
- 230000002183 duodenal effect Effects 0.000 claims description 10
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 10
- 210000003739 neck Anatomy 0.000 description 58
- 210000002784 stomach Anatomy 0.000 description 26
- 239000000463 material Substances 0.000 description 19
- 210000000813 small intestine Anatomy 0.000 description 17
- 210000004913 chyme Anatomy 0.000 description 15
- 210000000936 intestine Anatomy 0.000 description 13
- 235000013305 food Nutrition 0.000 description 11
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 10
- 206010021518 Impaired gastric emptying Diseases 0.000 description 7
- -1 MP35N Inorganic materials 0.000 description 7
- 229920000295 expanded polytetrafluoroethylene Polymers 0.000 description 7
- 210000004203 pyloric antrum Anatomy 0.000 description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- 238000004873 anchoring Methods 0.000 description 6
- 208000001288 gastroparesis Diseases 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 102000004877 Insulin Human genes 0.000 description 5
- 108090001061 Insulin Proteins 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- 230000001079 digestive effect Effects 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 229940125396 insulin Drugs 0.000 description 5
- 210000004379 membrane Anatomy 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 210000000214 mouth Anatomy 0.000 description 5
- 230000004044 response Effects 0.000 description 5
- 230000003068 static effect Effects 0.000 description 5
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 5
- 206010051153 Diabetic gastroparesis Diseases 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 210000003484 anatomy Anatomy 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 210000001630 jejunum Anatomy 0.000 description 4
- 210000003041 ligament Anatomy 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 229920004943 Delrin® Polymers 0.000 description 3
- 239000004812 Fluorinated ethylene propylene Substances 0.000 description 3
- 229910001226 L605 Inorganic materials 0.000 description 3
- 238000007681 bariatric surgery Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 229910000701 elgiloys (Co-Cr-Ni Alloy) Inorganic materials 0.000 description 3
- 210000003238 esophagus Anatomy 0.000 description 3
- 210000005095 gastrointestinal system Anatomy 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 229910001000 nickel titanium Inorganic materials 0.000 description 3
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 3
- 229920009441 perflouroethylene propylene Polymers 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 229910001220 stainless steel Inorganic materials 0.000 description 3
- 239000010935 stainless steel Substances 0.000 description 3
- 239000004696 Poly ether ether ketone Substances 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- JUPQTSLXMOCDHR-UHFFFAOYSA-N benzene-1,4-diol;bis(4-fluorophenyl)methanone Chemical compound OC1=CC=C(O)C=C1.C1=CC(F)=CC=C1C(=O)C1=CC=C(F)C=C1 JUPQTSLXMOCDHR-UHFFFAOYSA-N 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- HQQADJVZYDDRJT-UHFFFAOYSA-N ethene;prop-1-ene Chemical group C=C.CC=C HQQADJVZYDDRJT-UHFFFAOYSA-N 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 239000010419 fine particle Substances 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 235000012631 food intake Nutrition 0.000 description 2
- 210000003736 gastrointestinal content Anatomy 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 239000006193 liquid solution Substances 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 229920002530 polyetherether ketone Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000002861 polymer material Substances 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 229940058401 polytetrafluoroethylene Drugs 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- 238000009941 weaving Methods 0.000 description 2
- 230000004580 weight loss Effects 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 0 CCC1(CCC(C)C(C)C)C*CC1 Chemical compound CCC1(CCC(C)C(C)C)C*CC1 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010017943 Gastrointestinal conditions Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000014797 chronic intestinal pseudoobstruction Diseases 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229940039231 contrast media Drugs 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000011846 endoscopic investigation Methods 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000030136 gastric emptying Effects 0.000 description 1
- 230000014101 glucose homeostasis Effects 0.000 description 1
- 230000002641 glycemic effect Effects 0.000 description 1
- 210000003405 ileum Anatomy 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 238000002324 minimally invasive surgery Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000002644 neurohormonal effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 239000003538 oral antidiabetic agent Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 229920005597 polymer membrane Polymers 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000009958 sewing Methods 0.000 description 1
- 238000004513 sizing Methods 0.000 description 1
- 238000007682 sleeve gastrectomy Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 210000005070 sphincter Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000003356 suture material Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000006016 thyroid dysfunction Effects 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
- A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
- A61F5/0013—Implantable devices or invasive measures
- A61F5/0076—Implantable devices or invasive measures preventing normal digestion, e.g. Bariatric or gastric sleeves
- A61F5/0079—Pyloric or esophageal obstructions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
- A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
- A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
- A61F5/0013—Implantable devices or invasive measures
- A61F5/0036—Intragastrical devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
- A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
- A61F5/0013—Implantable devices or invasive measures
- A61F5/0076—Implantable devices or invasive measures preventing normal digestion, e.g. Bariatric or gastric sleeves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/02—Holding devices, e.g. on the body
- A61M25/04—Holding devices, e.g. on the body in the body, e.g. expansible
Definitions
- the instant disclosure relates generally to implants placed within gastrointestinal systems, including the esophagus, the stomach and the intestines. More particularly, it relates to devices and methods for implant systems having components implantable and removable using endoscopic techniques for treatment of obesity, diabetes, reflux, gastroparesis and other gastrointestinal conditions.
- Bariatric surgery procedures such as sleeve gastrectomy, the Roux-en-Y gastric bypass (RYGB) and the bileo-pancreatic diversion (BPD), modify food intake and/or absorption within the gastrointestinal system to effect weight loss in obese patients.
- These procedures affect metabolic processes within the gastrointestinal system, by either short circuiting certain natural pathways or creating different interactions between the consumed food, the digestive tract, its secretions and the neuro-hormonal system regulating food intake and metabolism.
- T2DM type-2 Diabetes Mellitus
- stents with active fixation means such as barbs that deeply penetrate into surrounding tissue, may potentially cause tissue necrosis and erosion of the implants through the tissue, which can lead to complications, such as bacterial infection of the mucosal tissue or systemic infection.
- implants due to the intermittent peristaltic motion within the digestive tract, implants such as stents have a tendency to migrate.
- Gastroparesis is a chronic, symptomatic disorder of the stomach that is characterized by delayed gastric emptying in the absence of mechanical obstruction.
- the cause of gastroparesis is unknown, but it may be caused by a disruption of nerve signals to the intestine.
- the three most common etiologies are diabetes mellitus, idiopathic, and postsurgical. Other causes include medication, Parkinson's disease, collagen vascular disorders, thyroid dysfunction, liver disease, chronic renal insufficiency, and intestinal pseudo-obstruction.
- DGP diabetic gastroparesis
- Diabetic gastroparesis affects about 40% of patients with type 1 diabetes and up to 30% of patients with type 2 diabetes and especially impacts those with long-standing disease. Both symptomatic and asymptomatic DGP seem to be associated with poor glycemic control by causing a mismatch between the action of insulin (or an oral hypoglycemic drug) and the absorption of nutrients. Treatment of gastroparesis depends on the severity of the symptoms.
- a gastrointestinal implant for use within a pylorus, a duodenal bulb, and a duodenum of a patient, the implant having an expanded configuration and a contracted configuration and comprising: a proximal portion comprising a hollow tubular braided structure of wire shaped to form a cylinder having a proximal end, a distal end, and a proximal wall extending radially inward from the proximal portion distal end, wherein the proximal wall has an outer circumference and an inner circumference and is configured with a first bias such that the inner circumference is located closer to the proximal portion proximal end than the proximal portion outer circumference; a neck portion comprising a cylinder having a proximal end and a distal end and extending distally from the inner circumference of the proximal portion, the neck portion having a length greater than a width of a pylorus; a distal portion comprising
- a gastrointestinal device for implanting within a pylorus, a duodenal bulb, and a duodenum of a patient's gastrointestinal tract, the device having a central axis and comprising a first expandable portion comprising a hollow tubular braided structure of wire and having a first cylinder extending parallel to the central axis, the first cylinder having a proximal end, a distal end, and a length and a first face located at the distal end of the first cylinder and oriented transverse to the central axis; a neck portion extending from the first face of the first expandable portion parallel to the central axis, the neck portion having a first end, a second end, a wall extending between the first end and second end, and a diameter sized to fit within a pylorus; and a second expandable portion comprising a hollow tubular braided structure of wire and having a second cylinder extending parallel to the central axis, the second cylinder
- a gastrointestinal device for implanting within a pylorus, a duodenal bulb, and a duodenum of a patient's gastrointestinal tract, the device comprising a first expandable portion comprising a hollow tubular braided structure of wire shaped to include a disk portion configured to be located on a stomach side of the pylorus; a central cylinder portion having a first end, a second end, and a diameter that fits within the pylorus; a second expandable portion comprising a hollow tubular braided structure of wire shaped to include a cylinder having a proximal end, and distal end, a length between the proximal end and distal end, and a disk portion to be located on an intestinal side of the pylorus, the second expandable portion including a structural element configured to resist circumferential compression; and an intestinal bypass sleeve comprising a sleeve portion, wherein the sleeve portion extends from the duodenal bulb into the
- FIG. 1 is a cross-sectional view of a portion of the digestive tract in a human body with a pyloric anchor and sleeve implanted in the pylorus.
- FIG. 2 is a cross-sectional view of a portion of the digestive tract in a human body with a pyloric anchor implanted and an intestinal bypass sleeve attached.
- FIG. 3 is a cross-sectional view of a portion of the digestive tract in a human body with a pyloric anchor implanted in the pylorus, showing a braided wire structure of the anchor according to some embodiments.
- FIG. 4 is a cross-sectional view of a portion of the digestive tract in a human body with a pyloric anchor implanted in the pylorus, showing an overall structure of the anchor and flanges according to some embodiments.
- FIG. 5 shows a pyloric implant from three points of view and illustrates an exemplary embodiment of a structural element having a ring configuration.
- FIG. 6 shows a pyloric implant from three points of view and illustrates an exemplary embodiment having multiple structural elements having a ring configuration.
- FIG. 7 shows a pyloric implant from three points of view and illustrates an exemplary embodiment having multiple structural elements having a ring configuration.
- FIG. 8 shows a pyloric implant from three points of view and illustrates an exemplary embodiment having multiple structural elements having a ring configuration.
- FIG. 9 shows a pyloric implant from three points of view and illustrates an exemplary embodiment of a structural element according to some configurations.
- FIG. 10 shows a pyloric implant from three points of view and illustrates an exemplary embodiment of a structural element according to some configurations.
- FIG. 11 shows a pyloric implant from three points of view and illustrates an exemplary embodiment of a structural element according to some configurations.
- FIG. 12 shows an exemplary embodiment of a structural element and a pyloric implant with a structural element attached, according to some configurations.
- FIG. 13 shows an exemplary embodiment of a structural element and a pyloric implant with a structural element attached, according to some configurations.
- FIG. 14 shows an exemplary embodiment of a structural element and a pyloric implant with a structural element attached, according to some configurations.
- FIG. 15 shows an exemplary embodiment of a structural element having rings and a pyloric implant with a structural element attached, according to some configurations.
- FIG. 16 shows an exemplary embodiment of a structural element and various views of a pyloric implant with a structural element attached, according to some configurations.
- FIG. 17 shows an exemplary embodiment of a structural element and various views of a pyloric implant with a structural element attached, according to some configurations.
- FIG. 18 shows an exemplary embodiment of a structural element and various views of a pyloric implant with a structural element attached, according to some configurations.
- FIG. 19 shows an exemplary embodiment of a structural element and various views of a pyloric implant with a structural element attached, according to some configurations.
- FIG. 20 shows an exemplary embodiment of a structural element and various views of a pyloric implant with a structural element attached, according to some configurations.
- FIG. 21 shows an exemplary embodiment of a structural element and various views of a pyloric implant with various structural elements attached, according to some configurations.
- FIG. 22 shows an exemplary embodiment of a structural element and various views of a pyloric implant with a structural element attached, according to some configurations.
- FIG. 23 shows an exemplary embodiment of a structural element and various views of a pyloric implant with a structural element attached, according to some configurations.
- FIG. 24 shows an exemplary embodiment of a structural element and various views of a pyloric implant with a structural element attached, according to some configurations.
- FIG. 25 is a perspective view of an exemplary pyloric implant with a proximal structural element and a distal structural element, according to some embodiments.
- FIG. 26 is a side view of an exemplary pyloric implant with a proximal structural element and a distal structural element, according to some embodiments.
- FIG. 27 is an axial view of an exemplary pyloric implant with a proximal structural element and a distal structural element, as viewed from the distal end, according to some embodiments.
- FIG. 28 is an axial view of an exemplary pyloric implant with a proximal structural element and a distal structural element, as viewed from the proximal end, according to some embodiments.
- FIG. 29 is an axial view of an exemplary structural element that can be used on a flange of an implant, according to some embodiments.
- FIGS. 30A and 30B are a side view of an exemplary structural element that can be used on a flange of an implant, according to some embodiments.
- FIG. 31 is a side view of an exemplary pyloric implant with a distal structural element and a proximal structural element in a contracted configuration, according to some embodiments.
- FIG. 32 is a side view of an exemplary pyloric implant, according to some embodiments.
- FIG. 33 is a perspective view of an exemplary implant having an intestinal bypass sleeve, according to some embodiments.
- FIG. 34 is a perspective view of an exemplary implant having an intestinal bypass sleeve, according to some embodiments.
- the present disclosure includes an apparatus and method to place and/or anchor a gastrointestinal device within the pyloric antrum, pylorus, duodenum and jejunum.
- the gastrointestinal device disclosed herein may be implanted by inserting it endoscopically (when the device is loaded into a delivery catheter) through the mouth, throat, stomach and intestines.
- the gastrointestinal device may include an anchor that can be implanted and remain within a pylorus.
- the gastrointestinal device may also include an expandable anchor having a flexible thin-walled sleeve attached to the distal end of the anchor.
- secondary anchors may also anchor other portions of the thin-walled sleeve.
- the instant disclosure may include an expandable anchor that can also be used to hold open the pylorus and may help to reduce the symptoms of gastroparesis by allowing the stomach contents to exit the stomach easier through the pylorus into the duodenum.
- the instant disclosure may include additional structure, such as an expandable anchor having a short bypass sleeve or no bypass sleeve.
- an active pumping means may also be attached to the expandable anchor to actively pump the stomach contents from the pyloric antrum into the duodenum.
- the present disclosure is an exemplary version of the apparatus and methods described in U.S. Pat. No. 9,044,300, entitled “Gastrointestinal Prostheses,” granted Jun. 2, 2015, which is incorporated herein by reference.
- the instant disclosure provides improvements on the performance of previously designed implants. Certain design improvements are generally intended to improve the anchoring performance of the implant and decrease the likelihood that the implant can migrate in response to physiological changes of the body. Additional improvements disclosed herein minimize the likelihood that the sleeve portion of the implant becomes everted or obstructed.
- FIG. 1 is a cross-sectional view of a portion of a human digestive track 10 , showing an embodiment of a device 100 that may be implanted between the stomach 16 and the small intestine 18 .
- the device 100 may be implanted generally within the pylorus 20 with at least a section configured to remain within the pyloric antrum 22 .
- the device 100 may be configured to be implanted with portions of the device 100 held within the stomach 16 , the pylorus 20 , and the small intestine 18 .
- the device 100 may be endoscopically implanted within the pylorus 20 in a compressed configuration. After implantation, the device 100 may be released and assume an expanded configuration. Once in the expanded configuration, the device 100 generally anchors itself to remain with at least a portion of the device 100 within the pylorus 20 .
- FIG. 2 is a cross-sectional view of a portion of the digestive tract in a human body showing the pyloric antrum 22 , pylorus 20 , duodenum 24 , and duodenal bulb 26 .
- FIG. 2 also shows the device 100 implanted between the stomach 16 and small intestine 18 .
- the device 100 may generally comprise an expandable portion 110 that holds or anchors the device 100 in place, and a sleeve portion 120 .
- the device 100 as a whole may be alternatively referred to as an implant, an implantable device, a gastrointestinal device, a gastrointestinal implant, or a pyloric implant.
- the portion of the device 100 that is able to expand and hold the device 100 in place after implantation may be referred to as the anchor, the anchoring portion, the holder, or the holding portion.
- the sleeve 120 portion of the device 100 that is shown within the small intestine 18 may be alternatively referred to as the sleeve, the intestinal sleeve, the bypass sleeve, the intestinal bypass sleeve, the liner, or the bypass liner.
- the device 100 may include an intestinal bypass sleeve 120 that is designed to be implanted in the duodenum 26 from the pylorus 20 to the ligament of treitz (not shown). As shown in FIG. 2 , the sleeve 120 is generally held in place in the small intestine 18 by the anchoring portion 110 of the device that anchors within or on the pylorus 20 .
- the sleeve 120 , the anchor 110 , or both are further coupled at or within the pylorus 20 using one or more of the techniques described in either of U.S. Pat. Nos. 8,211,186 or 8,282,598 filed Jul. 9, 2010, entitled “External Anchoring Configuration for Modular Gastrointestinal Prostheses,” both of which are incorporated herein by reference.
- the sleeve 120 may be configured to be coupled to the anchor 110 , using one or more of the configurations disclosed in U.S. Pat. No. 8,702,641, filed Jan. 7, 2011, entitled “Gastrointestinal Prostheses Having Partial Bypass Configurations,” which is incorporated herein by reference.
- FIG. 3 illustrates an exemplary embodiment of the anchor 110 .
- the anchor 110 has an overall cylindrical shape with a length and a width. In some embodiments, the anchor 110 has an overall cylindrical shape, with a central axis oriented along a longitudinal direction.
- the anchor 110 has a proximal portion 130 , a distal portion 132 , and a neck portion 134 .
- the proximal portion 130 is shaped in a circular or disk shape. In some embodiments, the proximal portion 130 is shaped in a circular or disk shape having a lip or rim.
- the proximal portion 130 may interchangeably be referred to as a proximal flange.
- the lip or rim may define a proximal portion proximal end 140 and a proximal portion distal end 142 .
- the lip or rim forming the proximal portion proximal end 140 and the proximal portion distal end 142 may define an overall cylindrical or tubular shape.
- the proximal portion 130 circular or disk shape defines a face or wall 148 also referred to herein as the proximal portion wall 148 or proximal flange wall.
- the proximal flange wall 148 may be a disk that is located on the distal side 142 of the proximal flange 130 .
- the proximal flange wall 148 may be a disk or disk shaped and oriented transverse to the central axis.
- the proximal end 140 of the proximal portion 130 is open to allow chyme to enter.
- the distal end 142 of the proximal portion 130 may be connected to the proximal flange wall 148 .
- the neck portion 134 defines a through-lumen 152 that allows chyme to flow from the stomach 16 to the small intestine 18 .
- the neck portion 134 may be rigid to hold the pylorus 20 open or it may be compliant to allow the opening and closure of the through lumen 152 with the pylorus 20 .
- the distal portion 132 is shaped in a circular or tubular shape. In some embodiments, the distal portion 132 is shaped in a circular, disk, or tubular shape having a lip or rim.
- the distal portion 132 may interchangeably be referred to as a distal flange.
- the lip or rim may define a distal portion proximal end 144 and a distal portion distal end 146 .
- the lip or rim forming the distal portion proximal end 144 and the distal portion distal end 146 may define an overall cylindrical or tubular shape.
- the distal portion 132 circular or disk shape defines a face or wall 150 also referred to herein as the distal portion wall 150 or distal flange wall.
- the distal flange wall 150 may be located on the proximal side of the distal flange 132 .
- the distal flange wall 150 may be formed as a disk or disk shaped that is oriented transverse to the central axis.
- the proximal end 144 of the distal portion 132 may be connected to the distal flange wall 150 .
- the distal portion 132 or distal flange is located in the duodenum and the distal flange 132 has an opening at the distal end 146 that faces the intestine 18 .
- the distal flange 132 , and the neck portion 134 each form a generally cylindrical shape, each with an independent diameter.
- the proximal flange 130 has an overall cylindrical shape with an open proximal end 140 having a first diameter, and a distal end 142 having a proximal flange wall 148 that necks down to a diameter of the neck portion 134 .
- the proximal flange wall 148 can be shaped having an angle with a bias in relation to the central axis.
- the neck portion 134 comprises a cylinder having a second diameter and extends between the proximal flange 130 and the distal flange 132 .
- the distal flange 132 has a generally cylindrical shape and includes the distal flange wall 150 starting from the neck portion 134 and expanding radially from the central axis.
- the distal flange 132 has a proximal end 144 that is positioned near the pylorus 20 , and a distal end 146 that faces into the small intestine 18 .
- the anchor can be oriented by a central axis that is defined as the direction traveling from the proximal flange 130 , through the neck portion 134 , and continuing through the distal flange 132 .
- the braided wire structure of the implant may be formed into a shape to promote anchoring to the tissue of a patient.
- the proximal flange wall 148 and distal flange wall 150 can be angled in relation to the neck portion 134 in order to provide certain spatial relationships to the pylorus 20 at particular locations.
- both the proximal flange 130 and distal flange 132 are shaped to apply force F to the proximal and distal face of the pylorus 20 , respectively. The effect of this force is intended to keep the implant in place, anchored across the pylorus 20 .
- the overall length of the anchor 110 can be from about 10.0 mm to about 100.0 mm, but varying sized anchors may be formed, depending on a patient's anatomy or anatomical fit.
- the anchor 110 length may be from about 10.0 mm to about 100 mm, from about 25.0 mm to about 75.0 mm, from about 40.0 mm to about 60.0 mm, or any length within these ranges.
- An exemplary anchor 110 has been formed that is about 50.0 mm long but typical anchors may be in the range of between about 45.0 mm and 55.0 mm.
- the diameter of the proximal flange 130 can be from about 10.0 mm to about 75.0 mm, or any range in between, for example from about 25.0 mm to about 60.0 mm, and from about 40.0 mm to about 55.0 mm.
- An exemplary anchor 110 has been formed with the diameter of the proximal flange 130 about 40.0 mm.
- the distal flange 132 is shaped as a cylinder with a generally open distal end 146 and partially restricted proximal end 144 connected to the distal flange wall 150 .
- the distal flange 132 may be formed in an overall cylindrical shape having a diameter.
- the length and diameter of the distal flange 132 can be sized to prevent canting or tilting within a tubular anatomical structure such as the duodenum.
- the diameter of the distal flange 132 may be from about 5.00 mm to about 60.0 mm, or any range in between, for example from about 20.0 mm to about 50.0 mm, or from about 30.0 mm to about 40.0 mm.
- the distal flange can have a length of roughly 18.0 mm and a diameter of 35.0 mm, to ensure the structure can remain positioned within a tubular anatomic structure such as the duodenal bulb with a diameter of about 40.0 mm.
- An exemplary anchor 110 has been formed with the diameter of the distal flange 132 about 35.0 mm in diameter.
- the diameter of the distal flange 132 may define a gap or space between the diameter of the distal flange 132 and the duodenum.
- a gap or space between the diameter of the distal flange 132 and the duodenum may allow the anchor 110 to rotate or turn in a direction generally perpendicular to the central axis of the anchor 110 or a longitudinal axis defined by the center of the opening of the pylorus. If the anchor 110 is allowed to rotate after it is implanted in a patient, the distal flange 132 or anchor 110 or both may undergo unwanted movement or deflection and in some cases become dislodged.
- Rotation or turning of the anchor 110 or the distal flange 132 may be inhibited by providing a distal flange 132 having a suitable length and diameter.
- a distal flange 132 length may allow the distal flange 132 to contact the duodenum and prevent further rotation before the distal flange 132 or anchor 110 become deflected or dislodged.
- the length of the distal flange 132 may determine the degree of rotation the anchor 110 may undergo before contacting the duodenum.
- the length and the diameter of the distal flange 132 are sized such that upon rotation or canting of the anchor 110 away from the longitudinal axis, the distal end 146 of the distal flange 132 will make contact with the intestinal wall and therefore will resist migration of the anchor 110 within a patient. It has been found that a suitable distal flange 132 length that may inhibit unwanted rotation or canting or longitudinal deflection may be from about 10.0 mm to about 50.0 mm or any length in between. In some embodiments, the distal flange 132 may have a length that is sized in relation to the width of the distal flange 132 .
- the distal flange 132 may have a length that is sized in relation to the length of the proximal flange 130 .
- the length of the distal flange 132 may be the same length as the proximal flange 130 .
- the length of the distal flange 132 may be multiples of the length of the proximal flange 130 .
- the distal flange 132 may be one and a half, two times, three times, or greater, the length of the proximal flange 130 .
- the diameter of the neck portion 134 may be from about 2.0 mm to about 30.0 mm, or any range in between. for example from about 5.00 mm to about 30.0 mm, and from about 10.0 mm to about 20.0 mm.
- An exemplary anchor 110 has been formed with the diameter of the neck portion 134 about 15.0 mm.
- the length of the neck portion 134 may be approximately the width of a patient's pylorus. In some embodiments, the length of the neck portion 134 may be longer than the width of a patient's pylorus to provide a gap between the proximal flange wall 148 and the distal flange wall 150 and the pylorus 20 . In some embodiments, the neck portion 134 may be sized to allow the proximal flange wall 148 and the distal flange wall 150 to contact the pylorus 20 . In some embodiments, the anchor 110 is compressible in diameter and the overall diameter can be reduced to about 5.00 to 10.0 mm in diameter typically to allow the anchor 110 to be loaded into a catheter (described further below).
- the anchor 110 is formed from a hollow tubular braided structure 160 of wire.
- the diameter of the wire that is used to form the braided structure 160 can range from about 0.001 inch to about 0.014 inch, from about 0.004 inch to about 0.011 inch, from about 0.006 inch to about 0.009 or any diameter within this range such as 0.008 inch
- the braided structure 160 of wire is weaved to form a mesh structure 162 .
- the mesh structure 162 may be shaped to form the various elements of the anchor 110 .
- the mesh structure 162 is formed into a shape with a proximal flange 130 , a neck portion 134 , and a distal flange 132 .
- the braided structure may be weaved to form a mesh structure 162 , and the mesh can be formed into various components.
- the mesh structure 162 may be formed into disks or cylinders of the various parts of the anchor 110 .
- Suitably sized cylinders may be formed from the mesh structure and may have a diameter from about 10 mm in diameter to about 70 mm in diameter, from about 14 mm to about 50 mm in diameter, and any diameter in between.
- a braided structure 160 of different diameters may be used at various locations of the anchor 110 .
- an anchor 110 may be created using a braided structure 160 having a diameter of about 14 mm for the neck portion 134 , a braided structure 160 having a diameter of about 34 mm for the distal flange 132 , and a braided structure 160 having a diameter of about 40 mm for the proximal flange 130 .
- the number of wire ends in the braided structure 160 is 96 ends, but it can range from 4 ends to 256 ends.
- the wire can be formed from a metal such as Nitinol, MP35N, L605, Elgiloy, stainless steel or from a plastic such as Pet, Peek or Delrin or other suitable material.
- the anchor 110 can be covered on the outside and/or inside side with a polymer membrane covering.
- the membrane covering the anchor 110 may be made from a thin-walled polymer material such as silicone, polyurethane, polytetrafluoroethylene, fluorinated ethylene propylene, polyethylene, expanded poly tetrafluoroethylene (ePTFE) or other suitable material.
- the wall thickness of the membrane covering the anchor 110 may be in the range of 0.001 inch to 0.030 inch thick.
- the membrane may be made by extrusion, dip coating from a liquid solution, powder coated from fine particles of polymer or paste extruded and then stretched as is the case with ePTFE.
- the anchor membrane may also be cut from a flat sheet of material such as ePTFE and then bonded or sewn into a disk shape or spherical shaped structure and then attached to the anchor 110 by sewing or gluing with a polymer such as FEP.
- the anchor 110 also incorporates a structural element contained within the overall structure.
- Various configurations of the structural element can be found in the following FIGS. 5 through 24 .
- FIG. 5 shows three views of the implant described in FIG. 3 and is intended to highlight an exemplary embodiment of an anchor 110 and a structural element 170 .
- a structural element 170 is located in any of the proximal flange 130 , the distal flange 132 , or both.
- a structural element 170 is located at least within the distal flange 132 .
- a structural element 170 may be located in the distal flange 132 , proximate the neck portion 134 , and may be weaved through the mesh structure 162 to maintain a suitable position.
- the structural element 170 is typically designed to provide support to the braided structure and contribute to resisting compression or deformation of the overall shape of the anchor 110 .
- the braided structure 160 alone will compress uniformly in response to a circumferential force and therefore the body may be able to push the implant from its location across the pylorus, leading to migration. With the structural element 170 in place, the implant is more resistant to compression due to the shape and resistance of the structural element 170 .
- the structural element 170 may deform independently from the braided structure 160 and therefore may provide support in addition to resistance to compression.
- the structural element 170 may provide support to the overall length, shape, diameter, or bias of the anchor 110 .
- the structural element 170 can be made from a metal such as Nitinol, MP35N, L605, Elgiloy, stainless steel or from a plastic such as PET, PEEK, or Delrin or other suitable material.
- the structural element 170 is made from superelastic Nitinol wire formed into the particular shape.
- the wire has a diameter from about 0.010 inch to about 0.030 inch, or from about 0.015 inch to about 0.025 inch, or any diameter in between.
- a structural element was formed from Nitinol wire having a diameter of about 0.020 inch in diameter.
- stiffening element having a particular rigidity or stiffness
- the size and material that the stiffening element is made from can be used to control these properties.
- Nitinol wire has been used to form stiffening elements, which have a compressive and expansive strength that is a function of the diameter of the wire used to make the stiffening element.
- the various components of the anchor 110 including the braided structure 160 , the mesh structure 162 , the mesh structure with a membrane, and the structural element 170 provide structural support both individually and in combination.
- the braided structure 160 and mesh structure 162 may contribute support both in a radial and longitudinal direction.
- the structural element 170 may enhance the overall strength and rigidity of the anchor both in the radial and longitudinal direction.
- the structural element 170 may be tailored to provide a bias to the braided structure 160 and mesh structure 162 to allow the anchor to form a particular shape in response to certain forces.
- the structural element 170 may add stiffness to the anchor 110 and allow it to maintain an effective circumference.
- the structural element 170 may provide a compression limit to the anchor 110 .
- the structural element 170 may add longitudinal stability.
- the structural element 170 may inhibit the anchor 110 from moving through the pylorus.
- the structural element 170 is comprised in the shape of a ring.
- the diameter of a ring formed to create a structural element may be sized to form a suitable fit for use in an anchor 110 , or at various locations on an anchor.
- the diameter of a ring may be from about 20 mm to about 50 mm, from about 25 mm to about 45 mm, from about 30 mm to about 40 mm, and any diameter within this range.
- a ring was formed having a diameter of about 35 mm.
- FIG. 6 describes an alternative embodiment to the implant shown in FIG. 5 .
- the anchor 110 incorporates a proximal structural element 172 .
- the proximal structural element 172 is located at the proximal wall or face 148 of the proximal flange 130 , nearest to the neck portion 134 of the anchor 110 .
- the function of the proximal structural element 172 is to resist compression of the overall structure.
- the proximal structural element 172 is weaved through the mesh structure 162 to secure it to the anchor 110 .
- the proximal structural 172 element may be made from the same material as the structural element 170 .
- FIG. 7 is an alternative embodiment to the implant shown in FIG. 5 .
- the anchor 110 incorporates two structural elements 174 , 176 each of which are 180 degrees apart, orientated out-of-plane relative to the distal wall or face 150 of the distal flange 132 .
- This configuration provides an additional option not available in the design shown in FIG. 5 by enabling the structure to be collapsed into a shape that can be loaded into a small diameter tube for the purpose of delivering or retrieving the implant endoscopically in a human. While the structural elements 174 , 176 can still resist circumferential compression, when the structure is pulled into a tube, the structural elements 174 , 176 will collapse into an elliptical shape.
- the structural elements 174 , 176 included here comprise rings.
- FIG. 8 is an additional embodiment to the implant shown in FIG. 7 in which the anchor 110 incorporates three structural elements 174 , 176 , 178 .
- the structural elements 174 , 176 , 178 comprise rings each 120 degrees apart from each of the others, orientated out-of-plane relative to the wall or face 150 of the distal flange 132 .
- This configuration provides an advantage over the design shown in FIG. 7 because it is symmetrical with respect to the distal flange 132 and with respect to a patient's anatomy.
- the overall structure can still be collapsed into a shape that can be loaded into a small diameter tube for the purpose of delivering or retrieving the implant endoscopically in a human.
- FIG. 9 illustrates an additional embodiment of an alternative structural element 190 .
- the anchor 110 incorporates a single alternative structural element 190 shaped to provide additional strength to the overall structure.
- This configuration provides an advantage over certain embodiments by enabling the structure to be collapsed more easily into a shape that can be loaded into a small diameter tube for the purpose of delivering or retrieving the implant endoscopically in a human. While the alternative structural element 190 can still resist circumferential compression, when the structure is pulled into a tube, the alternative structural element 190 will collapse into an elliptical shape.
- Various structural features also enable the anchor 110 containing an alternative structural element 190 to be collapsed and provide a bias to the direction of collapse.
- FIG. 10 illustrates an additional embodiment of an alternative structural element 190 .
- the anchor 110 incorporates an alternative structural element 190 shaped to provide additional strength to the overall implant structure. This configuration enables the structure to be collapsed into a shape that can be loaded into a small diameter tube for the purpose of delivering or retrieving the implant endoscopically in a human. While the alternative structural element 190 can still resist circumferential compression, when the structure is pulled into a tube, the alternative structural element 190 will collapse into an elliptical shape.
- Various structural features also enable the anchor 110 containing an alternative structural element 190 to be collapsed and provide a bias to the direction of collapse.
- FIGS. 11 to 20 illustrate various embodiments and shapes of an alternative structural element 190 .
- the embodiments shown in FIGS. 11 to 20 all have the features of providing additional strength to the overall structure of the anchor 110 and are collapsible.
- the illustrated embodiments enable the anchor 110 to be collapsed into a shape that can be loaded into a small diameter tube for the purpose of delivering or retrieving the implant endoscopically in a human.
- Various structural features also enable the anchor 110 containing an alternative structural element 190 to be collapsed and provide a bias to the direction of collapse.
- the anchor 110 illustrated in FIGS. 9 to 24 has the advantage that a structural element 190 has been added to provide structural support to the anchor 110 in addition to the braided structure 160 .
- the orientation of the structural element 190 is arranged to provide any of a static radial force, a static longitudinal force, or both.
- FIG. 13 contains an embodiment of a structural element 190 that is capable of providing both radial support and longitudinal support.
- longitudinal support refers to structural support for maintaining the anchor 110 in an expanded configuration along a direction parallel to the central axis.
- radial support refers to support for maintaining the anchor 110 in an expanded configuration along a direction perpendicular to the central axis. Often this can be accomplished by having the structural element 190 connected to the neck portion of the anchor 110 and transverse a flange in a radial direction.
- the structural element 190 is generally attached to the anchor 110 at various touch points.
- the shape and size of the structural element 190 can be chosen to provide a suitable fit for a particular patient. It may be that certain portions of an anchor 110 require greater longitudinal support. This can be accomplished by increasing the size of the structural element 190 in the longitudinal direction, as illustrated by comparing the structural element 190 in FIGS. 11 to 13 .
- a patient may need greater support in the longitudinal direction which can be accomplished by providing a compressive force by the anchor 110 in the longitudinal direction.
- Another option is to provide structural support in the longitudinal direction past the end of the distal flange. This may be accomplished by using the embodiment illustrated in FIG. 13 .
- the structural element 190 illustrated in FIG. 13 may be used, for example, to maintain a sleeve that is attached to the anchor 110 in an open configuration.
- a sleeve may be attached to the neck portion of the anchor 110 at the distal wall.
- the sleeve may be attached to the structural element 190 at various points along the sleeve as the sleeve extends through the end of the distal flange and continues out in a longitudinal direction.
- the structural element 190 is sized to extend past the end of the distal flange and thus a portion of the structural element 190 can be attached to the sleeve outside the distal flange.
- the sleeve is held away from the neck portion at a greater distance and thus the sleeve is prevented from everting or inverting into the neck portion.
- This embodiment may provide a more versatile arrangement as well when attaching a wider sleeve in, for example, a patient with a wider intestine, the structural element 190 can also be used to keep the sleeve open to allow food to enter the sleeve easier and continue on through the intestine.
- FIGS. 21 to 24 illustrate various embodiments and shapes of an alternative structural element 190 .
- the embodiments shown in FIGS. 21 to 24 all have the features of a structural element 190 providing additional strength to the overall structure of the anchor 110 and are collapsible.
- structural support can be provided to both the proximal flange and the distal flange with a single structural element 190 by providing a structural element 190 with a particular shape.
- the structural element 190 may be shaped with the structural element 190 contoured through or oriented longitudinal to the neck portion and extending through at least one flange. The points of attachment on both the neck portion and the flanges are selected to enable compressive and expansive forces to be transferred between the flanges and the neck portion by the structural element 190 .
- the structural element 190 traverses the neck portion of the anchor.
- the orientation and location of such a structural element 190 enables the structural element 190 to maintain the angle of each flange perpendicular to the neck portion. This allows each flange to resist circumferential compression while also preventing each flange from canting.
- the illustrated embodiments enable the anchor 110 to be collapsed into a shape that can be loaded into a small diameter tube for the purpose of delivering or retrieving the implant endoscopically in a human.
- Various structural features also enable the anchor 110 containing an alternative structural element 190 to be collapsed and provide a bias to the direction of collapse.
- the anchor 110 has a distal structural element comprised of three rings 193 , 194 , 196 attached to the distal flange 132 .
- the distal structural element 193 , 194 , 196 can be made from a metal such as Nitinol, MP35N, L605, Elgiloy, stainless steel or from a plastic such as PET, PEEK, or Delrin or other suitable material.
- the distal structural element 193 , 194 , 196 is made from superelastic Nitinol wire formed into the particular shape. In one example, a structural element was formed from three rings of Nitinol wire.
- the size and material that the stiffening element is made from can be used to control these properties.
- the Nitinol wire that has been used to form stiffening elements has a compressive and expansive strength that is a function of the diameter of the wire used to make the stiffening element.
- the distal structural element 193 , 194 , 196 may be formed of material having a thickness in the range from 0.010 inch to about 0.040 inch, or any range in between such as from about 0.015 inch to about 0.030, from about 0.020 inch to about 0.025 inch.
- a distal structural element 193 , 194 , 196 comprised a plurality of rings formed from material having a thickness of about 0.020 inch, or about 0.51 mm.
- each of the three rings that form the distal structural element 193 , 194 , 196 have the same diameter which are in the range of from 1.0 inch to 2.0 inches, and any range within such as from about 1.2 inches to about 1.8 inches, and from about 1.3 inches to about 1.7 inches.
- the distal structural element 193 , 194 , 196 comprised material formed into rings each having a diameter of about 1.38 inches, or about 35.0 mm.
- the three rings of the distal structural element 193 , 194 , 196 are arranged around the distal flange 132 and are attached to the distal flange 132 by being integrally woven into the flange material.
- the rings of the distal structural element 193 , 194 , 196 are attached by first weaving the formed wire of the rings though the braided structure of the distal flange 132 and then the wire ends are inserted into a sleeve and crimped or welded.
- each ring may be arranged with at least a portion of each ring attached to the distal flange distal end 146 and a portion attached to the distal flange distal wall 150 .
- each ring may be attached with at least a portion of each ring closer to the distal flange proximal end 144 and a portion attached to the distal flange distal wall 150 .
- the orientation of the structural element or rings are arranged to provide any of a static radial force, a static longitudinal force or both. Often this requires the structural element to receive radial support from the neck portion or the wall of the anchor. In some embodiments, such as those shown in FIGS. 21 to 24 , this is accomplished by providing a structural element with a particular shape. In some embodiments, the design of the structural element may incorporate a plurality of rings. The orientation of the rings relative to the wall or face of the flange can be designed to provide suitable static structure. This can be accomplished by placing the rings out-of-plane with the flange wall. In a structure incorporating rings for the structural element, the rings are generally attached to the implant at about four locations. The attachment locations are evenly spaced around the ring and enable the compressive and expansive forces to be transferred between the flanges and the structural element evenly.
- the anchor 110 may have a proximal structural element 172 attached to the proximal flange 130 .
- the proximal structural element 172 may also be referred to as a compression bias spring.
- the proximal structural element 172 may be constructed as a substantially circular frame having nodes 204 .
- the proximal structural element 172 may be constructed from the same material that forms the distal structural element 193 , 194 , 196 .
- the proximal structural element 172 may also provide structural support to the proximal flange 130 .
- the proximal structural element 172 generally has an overall frame that is compressible, yet also is rigid.
- the rigid proximal structural element 172 tends to impart additional strength to the proximal flange 130 and aids in keeping the proximal end 140 of the proximal flange 130 open.
- the proximal structural element 172 can be shaped to bias the collapse of the diameter of the anchor 110 for removal from a patient and for loading the device onto a delivery catheter for delivery within a patient.
- the anchor 110 may include a drawstring 192 .
- the drawstring may be attached to the proximal flange 130 .
- the drawstring 192 typically can be attached to the proximal flange 130 by weaving the drawstring 192 through the material of the proximal flange 130 .
- the drawstring may be weaved through the material of the proximal flange and have a portion of the drawstring forming a drawstring loop 205 .
- the drawstring 192 may be constructed from a string or suture that is weaved through alternating cells in the braided wire structure of the anchor 110 .
- the draw string loop 205 allows the drawstring 192 to be attached to a retraction tool, for example by a hook or a clamp.
- the drawstring 192 is simply a suture that is weaved through the proximal flange 130 .
- the drawstring may be separate from the proximal structural element 172 .
- the drawstring may be constructed from any range of suture material and may comprise a thin wire or cable.
- the drawstring 192 can be used to elastically contract the anchor 110 by connecting at least one loop 205 to a removal device (not shown) and by drawing into a sheath, for example a catheter.
- the drawstring 192 allows the proximal flange 130 to collapse to the diameter of the neck portion 134 .
- FIG. 27 shows the anchor 110 from an axial perspective looking down the longitudinal direction from the distal end 146 of the distal flange 132 .
- the distal flange 132 has an outer circumference 198 , defined by the outer most edge of the proximal end 144 or distal end 146 of the distal flange 132 , and an inner circumference 199 defined by the location where the distal flange distal wall 150 meets the neck portion 134 .
- the inner circumference 199 of the distal flange is the same circumference as a circumference of the neck portion 134 . As illustrated in FIG.
- the distal structural element 193 , 194 , 196 may be formed by placing three rings at equal distances from each other around the distal flange 132 to provide pressure outward from an inner circumference 199 , for example starting from the distal flange distal wall 150 , and push outward against the outer circumference 198 of the distal flange 132 .
- FIG. 28 illustrates the proximal structural element 172 and the drawstring 192 within the proximal flange 130 of the anchor 110 as viewed from an axial perspective looking down the longitudinal direction from the proximal end 140 of the proximal flange 130 .
- the proximal flange 130 has an outer circumference 208 , defined by the outer most edge of the proximal end 140 or distal end 142 of the proximal flange 130 , and an inner circumference 209 defined by the location where the proximal flange proximal wall 148 meets the neck portion 134 (shown in FIG. 26 ).
- the inner circumference 209 of the proximal flange 130 is the same as a circumference of the neck portion 134 .
- FIG. 29 illustrates an embodiment of the proximal structural element 172 without the anchor, to illustrate an overall shape and structure.
- FIG. 29 shows the proximal structural element 172 as viewed from an axial perspective looking down the longitudinal direction and shows the proximal structural element 172 having a main body 212 that is substantially circular and having a diameter 214 .
- the proximal structural element diameter 214 may be in the range of from 1.0 inch to 2.0 inches, and any range in between such as from about 1.3 inches to about 1.8 inches, or from about 1.5 inches to about 1.7 inches.
- the proximal structural element main body 212 comprised a ring having a diameter of about 1.57 inches, or about 40.0 mm.
- the proximal structural element 172 may be formed of material having a thickness in the range from 0.015 inch to about 0.045 inch, or any range within such as from about 0.020 inch to about 0.035 inch, from about 0.025 inch to about 0.030 inch. In an example embodiment, a proximal structural element 172 was formed from material having a thickness of about 0.025 inch, or about 0.64 mm.
- the proximal structural element main body 212 has an overall planar structure, with the nodes 204 extending from the plane of the main body 212 .
- the nodes may be at an angle 214 to the plane of the main body 212 , for example the nodes 204 may be formed to extend at a 60 degree angle from the main body 212 .
- the nodes 204 may each have an outer loop 213 and an inner curve 215 .
- the outer loop 213 allows a bias for the proximal structural element 172 to collapse radially in response to a compressive force.
- the angle 214 helps to collapse the anchor in a uniform manner when the drawstring is pulled.
- the angle 214 of each node 204 allows for evenly distributed tension to be imparted to the main body 212 without forming a pinch point.
- the angle 214 also forms a shape that allows the anchor a bias toward a retracted configuration when tension is placed on the drawstring 172 .
- the anchor 110 may be may be configured to collapse into a narrower size.
- the anchor 110 may be collapsed into a narrower diameter for placement or removal from a patient.
- FIG. 31 shows the proximal flange 130 of the anchor 110 in the collapsed stage.
- the anchor can be collapsed by pulling the drawstring.
- the drawstring node 205 may be pulled away from the anchor 110 , collapsing the proximal structural element 172 .
- FIG. 31 shows the proximal flange 130 in a collapsed stage after the drawstring 192 has been pulled.
- the proximal flange wall 148 and the distal flange wall 150 may be constructed with a bias in relation to the central axis.
- the structural element 170 may also be configured to impart a bias on the distal flange wall 150 .
- the proximal structural element (not shown) may also impart a similar bias on the proximal flange wall 148 .
- the structural element 170 may be configured to impart a bias against the distal flange wall 150 in the proximal direction.
- the distal structural element 170 may be configured to impart a bias against the distal flange wall 150 in the proximal direction.
- the proximal flange wall 148 and the distal flange wall 150 may not be a completely flat configuration, but instead may have an angle, curve, or slope.
- the neck portion of the anchor has a length 216 .
- the distance 218 between the outer circumference ( 208 in FIG. 28 ) of the proximal flange wall 148 and the outer circumference ( 198 in FIG. 27 ) of the distal flange wall 150 may be less than the length of the neck portion 216 .
- the proximal flange wall 148 has a proximal gap 200 and the distal flange wall has a distal gap 202 .
- the proximal gap 200 is defined by the difference in the longitudinal location of the proximal flange wall 148 at the outer circumference ( 208 in FIG. 28 ) and the inner circumference ( 209 in FIG. 28 ).
- the distal gap 202 is defined by the difference in the longitudinal location of the distal flange wall 150 at the outer circumference ( 198 in FIG. 27 ) and the inner circumference ( 199 in FIG. 27 ).
- FIGS. 33 and 34 show an exemplary sleeve 120 that may be used in conjunction with an anchor.
- the sleeve 120 may be attached to the anchor 110 and be placed within the small intestine 18 .
- the sleeve 120 is integrally formed with or coupled to the anchor 110 .
- the sleeve 120 is removably or releasably coupled to the anchor 110 .
- an overall schematic of a sleeve includes a mouth 220 , a sleeve body 222 , and a neck 224
- the sleeve body 222 diameter is generally sized to match the diameter of the human small intestine.
- the diameter decreases at the neck 224 to be consistent with the inner diameter of the anchor. This change in diameter also helps to prevent sleeve eversion in which the sleeve folds back into itself in response to an increase in pressure on the outside of the sleeve.
- the sleeve body has a thickness of between about 0.001 and about 0.015 inches.
- the sleeve neck 224 is intended to be thicker than the sleeve body 222 , for example 0.005 inches versus 0.001 inches thick, to provide a second mechanism to prevent sleeve eversion.
- the thicker neck 224 collapses and does not fold back on itself. This mechanism essentially creates a duck-bill valve.
- the sleeve 120 can vary in length from 1.0-2.0 inches in length up to several feet. In some embodiments, the sleeve 120 bypasses the length of the duodenum up to the ligament of treitz. While various embodiments disclosed herein describe the intestinal bypass sleeve 120 as extending into the duodenum, in all such embodiments, it is also contemplated that the intestinal bypass sleeve 120 has a length sufficient to allow it to extend partially or fully into the jejunum. Often the length of the sleeve is dictated by the required mechanism of action. It has been shown that an effective sleeve length is one that allows it to reach the proximal jejunum; this location corresponds to the location of the ligament of Trietz.
- the length of the sleeve is determined based on the desired clinical outcome. Recent scientific research has indicated that a sleeve roughly 2 feet in length is sufficient to modify the transport and absorption of food and organ secretions within the small intestine, leading to remission of type 2 diabetes.
- the intestinal bypass sleeve 120 may be made from a thin-walled polymer material such as silicone, polyurethane, polytetrafluoroethylene, fluorinated ethylene propylene, polyethylene, expanded polytetrafluoroethylene (ePTFE) or other suitable material.
- the wall thickness of the intestinal bypass sleeve 120 may be between 0.0006 inch and 0.010 inch thick.
- the intestinal bypass sleeve 120 may be made by extrusion, into a tubular form or a lay flat tubing, dip coated from a liquid solution, powder coated from fine particles of polymer or paste extruded and then stretched as is the case with ePTFE.
- the gastrointestinal device thus described comprises an anchor configured to be implanted and remain within a pylorus of a patient.
- the gastrointestinal device may comprise an anchor having a flexible thin-walled sleeve attached to the distal end of the anchor.
- secondary anchors may also anchor other portions of the thin-walled sleeve.
- the anchor may be placed within a pylorus of a patient to assist in opening a pylorus of the patient.
- the sleeve may be placed within the intestine of the patient and held in place by the anchor.
- the device thus described may function as follows.
- the food As a person ingests food, the food enters the mouth, is chewed, and then proceeds down the esophagus and into the stomach. The food mixes with enzymes in the mouth and in the stomach. The stomach converts the food to a semi-fluid substance called chyme. The chyme enters the pyloric antrum and exits the stomach through the pylorus.
- the pylorus (or pyloric sphincter) is a band of muscle that functions to adjust the diameter of the pyloric orifice, which in turn effects the rate at which chyme exits the stomach.
- the pylorus (or phyloric sphincter or pyloric wall) also has a width (or thickness), which is the distance that the pylorus extends between the stomach and the duodenum.
- a gastrointestinal implant placed within the pylorus of a patent can be employed to control the opening and closing of the pylorus to control the flow rate of chyme from the stomach to the intestine of the patient.
- An exemplary gastrointestinal implant has been formed that can assume both an expanded and contracted configuration.
- the implant has a neck portion that allows chyme to flow from the stomach to the intestine of a patient.
- the width of the neck portion can be designed to control the flow rate of chyme from the stomach to the intestine.
- the flow rate of chyme can optionally be modified depending on the suitable blood glucose levels of the patient.
- the gastrointestinal implant may be held in place within a pylorus of a patient by using an anchor.
- the anchor comprises a proximal flange and a distal flange connected to the neck portion to anchor the neck portion in place.
- the proximal flange is configured to remain on the stomach side of a patient's pylorus and the distal flange is configured to remain on the intestinal side of a patient's pylorus.
- the widths of the proximal flange and distal flange in the expanded configuration are wider than the maximum diameter of the pylorus.
- the length of the neck portion can be configured to provide an optimum fit within the pylorus of a patient while preventing the neck portion from agitating the tissue of the pylorus. It has been discovered that an optimum length of the neck portion reduces agitation of the tissue of the pylorus by the anchor by reducing contact between the proximal and distal flanges of the anchor and the pyloric wall. By creating the neck portion to be longer than the width of the pyloric wall, the proximal flange and distal flange are arranged such that they have minimal contact with the pylorus as the pylorus opens and closes.
- the shape of the proximal flange and distal flange can be formed to include a bias that reduces contact with the pylorus as the pylorus opens and closes.
- the proximal flange and distal flange may be formed to provide a space between the proximal flange and distal flange and the pylorus.
- the anchor may be formed from material having a hollow tubular braided structure that can assume a collapsed configuration for placement within and removal from a patient's digestive system.
- the hollow tubular braided structure also can assume an expanded configuration for suitable placement within a patient's digestive track.
- the anchor may include a structural element that provides additional structural support to the anchor and keeps the anchor in an expanded configuration yet also allows the anchor to be compressed for ease of placement within and extraction from a patient.
- a structural element can be placed within the distal flange to provide structural support in the radial direction and thus prevent the distal flange from reverting into the stomach of a patient.
- a drawstring may be placed within the proximal flange to provide structural support in the radial direction and prevent the proximal flange from traveling into the intestine of a patient.
- Both the structural elements can be configured to be compressed into a collapsed configuration to allow the anchor to be placed within and removed from within a patient's digestive track.
- the neck portion of the anchor can be tailored to span the pylorus, and may be tailored to fit various patients of various dimensions. Additionally, the length of the neck portion can be tailored to extend past the pylorus to reduce a compressive force exerted by the flanges onto the pylorus.
- the length of the neck portion can be designed to sit within the patient's anatomy without continuous contact with the walls of the duodenal bulb and pyloric antrum.
- the diameter of the neck portion can also be sized to allow food to pass from a patient's stomach to intestine yet remain narrow enough to prevent it from propping open the pylorus.
- the small intestine is about 21 feet long in adults.
- the small intestine is comprised of three sections: the duodenum, jejunum , and ileum.
- the duodenum is the first portion of the small intestine and is typically 10.0 -12.0 inches long.
- the duodenum is comprised of four sections: the superior, descending, horizontal and ascending.
- the duodenum ends at the ligament of treitz.
- the duodenal bulb is the portion of the duodenum which is closest to the stomach.
- Suitably designed sleeves can be sized wherein the length of the sleeve determines at what point the chyme is allowed to contact the intestine. The design and length of the sleeve also determines at what point food that is traveling through the sleeve comes into contact with digestive juices.
- the gastrointestinal implant described here in can be placed within a patient's digestive track by inserting an endoscope through the mouth, esophagus and stomach to the pylorus.
- An over-the-wire sizing balloon is inserted through the working channel of the endoscope over a guidewire and is advanced across the pyloric opening.
- the balloon is inflated with saline or contrast media to a low pressure to open the pylorus and duodenum and allow measurement of the lumen diameter of the pyloric antrum, pylorus and duodenal bulb.
- blood glucose levels can be measured by a glucose sensor and the insulin infusion rates and optimum chyme flow rates can be set by the diameter of the neck portion.
- a glucose sensor monitors blood glucose levels and then based on their insulin levels inject themselves with insulin either with a syringe or with an infusion pump. Gastric emptying rates vary depending upon the composition of the food eaten. Sugars pass quickly from the stomach into the small intestine and protein and fats move from the stomach into the small intestine more slowly. Blood sugar control can be difficult to manage if the flow rate of chyme from the stomach to the small intestine is unpredictable and in the case of patients with gastroparesis the chyme flow rate can be very slow to zero.
- the disclosure herein described will allow for a tighter glucose level control by allowing more precise control of the flow rate of chyme into small intestine and modulating the flow rate of chyme base on blood glucose levels and insulin infusion rate.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Vascular Medicine (AREA)
- Nursing (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Prostheses (AREA)
Abstract
A gastrointestinal device for implanting within a patient's gastrointestinal tract, the device having a central axis and a first expandable portion comprising a hollow tubular braided structure of wire and having a first cylinder extending parallel to the central axis, the first cylinder having a length and a first face; a neck portion extending from the first face of the first expandable portion parallel to the central axis, the neck portion having a first end, a second end, a wall extending between the first end and second end, and a diameter sized to fit within a pylorus; and a second expandable portion comprising a hollow tubular braided structure of wire and having a second cylinder extending parallel to the central axis, the second cylinder having a second face located at the proximal end of the second cylinder and oriented transverse to the central axis.
Description
- This application is a continuation of U.S. application Ser. No. 15/489,444 filed Apr. 17, 2017, which is a continuation of U.S. application Ser. No. 15/060,418 filed Mar. 3, 2016, now U.S. Pat. No. 9.622,897, both of which are herein incorporated by reference in their entirety.
- The instant disclosure relates generally to implants placed within gastrointestinal systems, including the esophagus, the stomach and the intestines. More particularly, it relates to devices and methods for implant systems having components implantable and removable using endoscopic techniques for treatment of obesity, diabetes, reflux, gastroparesis and other gastrointestinal conditions.
- Bariatric surgery procedures, such as sleeve gastrectomy, the Roux-en-Y gastric bypass (RYGB) and the bileo-pancreatic diversion (BPD), modify food intake and/or absorption within the gastrointestinal system to effect weight loss in obese patients. These procedures affect metabolic processes within the gastrointestinal system, by either short circuiting certain natural pathways or creating different interactions between the consumed food, the digestive tract, its secretions and the neuro-hormonal system regulating food intake and metabolism. In the last few years there has been a growing clinical consensus that obese patients who undergo bariatric surgery see a remarkable resolution of their type-2 Diabetes Mellitus (T2DM) soon after the procedure. The remarkable resolution of diabetes after RYGB and BPD typically occurs too fast to be accounted for by weight loss alone, suggesting there may be a direct impact on glucose homeostasis. The mechanism of this resolution of T2DM is not well understood, and it is quite likely that multiple mechanisms are involved.
- One of the drawbacks of bariatric surgical procedures is that they require fairly invasive surgery with potentially serious complications and long patient recovery periods. In recent years, there has been increased effort to develop minimally invasive procedures to mimic the effects of bariatric surgery. One such procedure involves the use of gastrointestinal implants that modify transport and absorption of food and organ secretions. For example, U.S. Pat. No. 7,476,256 describes an implant having a tubular sleeve with anchoring barbs, which offer the physician limited flexibility and are not readily removable or replaceable. Moreover, stents with active fixation means, such as barbs that deeply penetrate into surrounding tissue, may potentially cause tissue necrosis and erosion of the implants through the tissue, which can lead to complications, such as bacterial infection of the mucosal tissue or systemic infection. Also, due to the intermittent peristaltic motion within the digestive tract, implants such as stents have a tendency to migrate.
- Gastroparesis is a chronic, symptomatic disorder of the stomach that is characterized by delayed gastric emptying in the absence of mechanical obstruction. The cause of gastroparesis is unknown, but it may be caused by a disruption of nerve signals to the intestine. The three most common etiologies are diabetes mellitus, idiopathic, and postsurgical. Other causes include medication, Parkinson's disease, collagen vascular disorders, thyroid dysfunction, liver disease, chronic renal insufficiency, and intestinal pseudo-obstruction. The prevalence of diabetic gastroparesis (DGP) appears to be higher in women than in men, for unknown reasons.
- Diabetic gastroparesis affects about 40% of patients with type 1 diabetes and up to 30% of patients with type 2 diabetes and especially impacts those with long-standing disease. Both symptomatic and asymptomatic DGP seem to be associated with poor glycemic control by causing a mismatch between the action of insulin (or an oral hypoglycemic drug) and the absorption of nutrients. Treatment of gastroparesis depends on the severity of the symptoms.
- Disclosed herein is a gastrointestinal implant for use within a pylorus, a duodenal bulb, and a duodenum of a patient, the implant having an expanded configuration and a contracted configuration and comprising: a proximal portion comprising a hollow tubular braided structure of wire shaped to form a cylinder having a proximal end, a distal end, and a proximal wall extending radially inward from the proximal portion distal end, wherein the proximal wall has an outer circumference and an inner circumference and is configured with a first bias such that the inner circumference is located closer to the proximal portion proximal end than the proximal portion outer circumference; a neck portion comprising a cylinder having a proximal end and a distal end and extending distally from the inner circumference of the proximal portion, the neck portion having a length greater than a width of a pylorus; a distal portion comprising a hollow tubular braided structure of wire shaped to form a cylinder extending distally from the neck portion and having a proximal end, a distal end, and a distal wall extending radially inward from the distal portion proximal end, wherein the distal wall has an outer circumference and an inner circumference and is configured with a second bias such that the inner circumference is located closer to the distal portion distal end than the distal portion outer circumference; and a structural element coupled to the distal portion and configured to resist circumferential compression.
- Also disclosed herein is a gastrointestinal device for implanting within a pylorus, a duodenal bulb, and a duodenum of a patient's gastrointestinal tract, the device having a central axis and comprising a first expandable portion comprising a hollow tubular braided structure of wire and having a first cylinder extending parallel to the central axis, the first cylinder having a proximal end, a distal end, and a length and a first face located at the distal end of the first cylinder and oriented transverse to the central axis; a neck portion extending from the first face of the first expandable portion parallel to the central axis, the neck portion having a first end, a second end, a wall extending between the first end and second end, and a diameter sized to fit within a pylorus; and a second expandable portion comprising a hollow tubular braided structure of wire and having a second cylinder extending parallel to the central axis, the second cylinder having a proximal end a distal end and a length and a second face located at the proximal end of the second cylinder and oriented transverse to the central axis wherein the length of the second cylinder is greater than one centimeter.
- A gastrointestinal device for implanting within a pylorus, a duodenal bulb, and a duodenum of a patient's gastrointestinal tract, the device comprising a first expandable portion comprising a hollow tubular braided structure of wire shaped to include a disk portion configured to be located on a stomach side of the pylorus; a central cylinder portion having a first end, a second end, and a diameter that fits within the pylorus; a second expandable portion comprising a hollow tubular braided structure of wire shaped to include a cylinder having a proximal end, and distal end, a length between the proximal end and distal end, and a disk portion to be located on an intestinal side of the pylorus, the second expandable portion including a structural element configured to resist circumferential compression; and an intestinal bypass sleeve comprising a sleeve portion, wherein the sleeve portion extends from the duodenal bulb into the duodenum.
- While multiple embodiments are disclosed, still other embodiments of the present invention will become apparent to those skilled in the art from the following detailed description, which shows and describes illustrative embodiments of the invention. Accordingly, the drawings and detailed description are to be regarded as illustrative in nature and not restrictive.
-
FIG. 1 is a cross-sectional view of a portion of the digestive tract in a human body with a pyloric anchor and sleeve implanted in the pylorus. -
FIG. 2 is a cross-sectional view of a portion of the digestive tract in a human body with a pyloric anchor implanted and an intestinal bypass sleeve attached. -
FIG. 3 is a cross-sectional view of a portion of the digestive tract in a human body with a pyloric anchor implanted in the pylorus, showing a braided wire structure of the anchor according to some embodiments. -
FIG. 4 is a cross-sectional view of a portion of the digestive tract in a human body with a pyloric anchor implanted in the pylorus, showing an overall structure of the anchor and flanges according to some embodiments. -
FIG. 5 shows a pyloric implant from three points of view and illustrates an exemplary embodiment of a structural element having a ring configuration. -
FIG. 6 shows a pyloric implant from three points of view and illustrates an exemplary embodiment having multiple structural elements having a ring configuration. -
FIG. 7 shows a pyloric implant from three points of view and illustrates an exemplary embodiment having multiple structural elements having a ring configuration. -
FIG. 8 shows a pyloric implant from three points of view and illustrates an exemplary embodiment having multiple structural elements having a ring configuration. -
FIG. 9 shows a pyloric implant from three points of view and illustrates an exemplary embodiment of a structural element according to some configurations. -
FIG. 10 shows a pyloric implant from three points of view and illustrates an exemplary embodiment of a structural element according to some configurations. -
FIG. 11 shows a pyloric implant from three points of view and illustrates an exemplary embodiment of a structural element according to some configurations. -
FIG. 12 shows an exemplary embodiment of a structural element and a pyloric implant with a structural element attached, according to some configurations. -
FIG. 13 shows an exemplary embodiment of a structural element and a pyloric implant with a structural element attached, according to some configurations. -
FIG. 14 shows an exemplary embodiment of a structural element and a pyloric implant with a structural element attached, according to some configurations. -
FIG. 15 shows an exemplary embodiment of a structural element having rings and a pyloric implant with a structural element attached, according to some configurations. -
FIG. 16 shows an exemplary embodiment of a structural element and various views of a pyloric implant with a structural element attached, according to some configurations. -
FIG. 17 shows an exemplary embodiment of a structural element and various views of a pyloric implant with a structural element attached, according to some configurations. -
FIG. 18 shows an exemplary embodiment of a structural element and various views of a pyloric implant with a structural element attached, according to some configurations. -
FIG. 19 shows an exemplary embodiment of a structural element and various views of a pyloric implant with a structural element attached, according to some configurations. -
FIG. 20 shows an exemplary embodiment of a structural element and various views of a pyloric implant with a structural element attached, according to some configurations. -
FIG. 21 shows an exemplary embodiment of a structural element and various views of a pyloric implant with various structural elements attached, according to some configurations. -
FIG. 22 shows an exemplary embodiment of a structural element and various views of a pyloric implant with a structural element attached, according to some configurations. -
FIG. 23 shows an exemplary embodiment of a structural element and various views of a pyloric implant with a structural element attached, according to some configurations. -
FIG. 24 shows an exemplary embodiment of a structural element and various views of a pyloric implant with a structural element attached, according to some configurations. -
FIG. 25 is a perspective view of an exemplary pyloric implant with a proximal structural element and a distal structural element, according to some embodiments. -
FIG. 26 is a side view of an exemplary pyloric implant with a proximal structural element and a distal structural element, according to some embodiments. -
FIG. 27 is an axial view of an exemplary pyloric implant with a proximal structural element and a distal structural element, as viewed from the distal end, according to some embodiments. -
FIG. 28 is an axial view of an exemplary pyloric implant with a proximal structural element and a distal structural element, as viewed from the proximal end, according to some embodiments. -
FIG. 29 is an axial view of an exemplary structural element that can be used on a flange of an implant, according to some embodiments. -
FIGS. 30A and 30B are a side view of an exemplary structural element that can be used on a flange of an implant, according to some embodiments. -
FIG. 31 is a side view of an exemplary pyloric implant with a distal structural element and a proximal structural element in a contracted configuration, according to some embodiments. -
FIG. 32 is a side view of an exemplary pyloric implant, according to some embodiments. -
FIG. 33 is a perspective view of an exemplary implant having an intestinal bypass sleeve, according to some embodiments. -
FIG. 34 is a perspective view of an exemplary implant having an intestinal bypass sleeve, according to some embodiments. - According to some embodiments, the present disclosure includes an apparatus and method to place and/or anchor a gastrointestinal device within the pyloric antrum, pylorus, duodenum and jejunum. The gastrointestinal device disclosed herein may be implanted by inserting it endoscopically (when the device is loaded into a delivery catheter) through the mouth, throat, stomach and intestines. The gastrointestinal device may include an anchor that can be implanted and remain within a pylorus. The gastrointestinal device may also include an expandable anchor having a flexible thin-walled sleeve attached to the distal end of the anchor. In some embodiments, secondary anchors may also anchor other portions of the thin-walled sleeve.
- The instant disclosure may include an expandable anchor that can also be used to hold open the pylorus and may help to reduce the symptoms of gastroparesis by allowing the stomach contents to exit the stomach easier through the pylorus into the duodenum. The instant disclosure may include additional structure, such as an expandable anchor having a short bypass sleeve or no bypass sleeve. In some embodiments, an active pumping means may also be attached to the expandable anchor to actively pump the stomach contents from the pyloric antrum into the duodenum.
- The present disclosure is an exemplary version of the apparatus and methods described in U.S. Pat. No. 9,044,300, entitled “Gastrointestinal Prostheses,” granted Jun. 2, 2015, which is incorporated herein by reference. The instant disclosure provides improvements on the performance of previously designed implants. Certain design improvements are generally intended to improve the anchoring performance of the implant and decrease the likelihood that the implant can migrate in response to physiological changes of the body. Additional improvements disclosed herein minimize the likelihood that the sleeve portion of the implant becomes everted or obstructed.
-
FIG. 1 is a cross-sectional view of a portion of a humandigestive track 10, showing an embodiment of adevice 100 that may be implanted between thestomach 16 and thesmall intestine 18. As shown inFIG. 1 , thedevice 100 may be implanted generally within the pylorus 20 with at least a section configured to remain within thepyloric antrum 22. Thedevice 100 may be configured to be implanted with portions of thedevice 100 held within thestomach 16, thepylorus 20, and thesmall intestine 18. Thedevice 100 may be endoscopically implanted within the pylorus 20 in a compressed configuration. After implantation, thedevice 100 may be released and assume an expanded configuration. Once in the expanded configuration, thedevice 100 generally anchors itself to remain with at least a portion of thedevice 100 within thepylorus 20. -
FIG. 2 is a cross-sectional view of a portion of the digestive tract in a human body showing thepyloric antrum 22,pylorus 20,duodenum 24, andduodenal bulb 26.FIG. 2 also shows thedevice 100 implanted between thestomach 16 andsmall intestine 18. As shown inFIG. 2 , thedevice 100 may generally comprise anexpandable portion 110 that holds or anchors thedevice 100 in place, and asleeve portion 120. - The
device 100 as a whole may be alternatively referred to as an implant, an implantable device, a gastrointestinal device, a gastrointestinal implant, or a pyloric implant. The portion of thedevice 100 that is able to expand and hold thedevice 100 in place after implantation may be referred to as the anchor, the anchoring portion, the holder, or the holding portion. Thesleeve 120 portion of thedevice 100 that is shown within thesmall intestine 18 may be alternatively referred to as the sleeve, the intestinal sleeve, the bypass sleeve, the intestinal bypass sleeve, the liner, or the bypass liner. For example, thedevice 100 may include anintestinal bypass sleeve 120 that is designed to be implanted in the duodenum 26 from the pylorus 20 to the ligament of treitz (not shown). As shown inFIG. 2 , thesleeve 120 is generally held in place in thesmall intestine 18 by the anchoringportion 110 of the device that anchors within or on thepylorus 20. - According to various embodiments, the
sleeve 120, theanchor 110, or both are further coupled at or within thepylorus 20 using one or more of the techniques described in either of U.S. Pat. Nos. 8,211,186 or 8,282,598 filed Jul. 9, 2010, entitled “External Anchoring Configuration for Modular Gastrointestinal Prostheses,” both of which are incorporated herein by reference. According to various embodiments of the invention, thesleeve 120 may be configured to be coupled to theanchor 110, using one or more of the configurations disclosed in U.S. Pat. No. 8,702,641, filed Jan. 7, 2011, entitled “Gastrointestinal Prostheses Having Partial Bypass Configurations,” which is incorporated herein by reference. -
FIG. 3 illustrates an exemplary embodiment of theanchor 110. Theanchor 110 has an overall cylindrical shape with a length and a width. In some embodiments, theanchor 110 has an overall cylindrical shape, with a central axis oriented along a longitudinal direction. Theanchor 110 has aproximal portion 130, adistal portion 132, and aneck portion 134. - In some embodiments, the
proximal portion 130 is shaped in a circular or disk shape. In some embodiments, theproximal portion 130 is shaped in a circular or disk shape having a lip or rim. Theproximal portion 130 may interchangeably be referred to as a proximal flange. The lip or rim may define a proximal portionproximal end 140 and a proximal portiondistal end 142. The lip or rim forming the proximal portionproximal end 140 and the proximal portiondistal end 142 may define an overall cylindrical or tubular shape. In some embodiments, theproximal portion 130 circular or disk shape defines a face orwall 148 also referred to herein as theproximal portion wall 148 or proximal flange wall. Theproximal flange wall 148 may be a disk that is located on thedistal side 142 of theproximal flange 130. Theproximal flange wall 148 may be a disk or disk shaped and oriented transverse to the central axis. In general, theproximal end 140 of theproximal portion 130 is open to allow chyme to enter. Thedistal end 142 of theproximal portion 130 may be connected to theproximal flange wall 148. - In some embodiments, the
neck portion 134 defines a through-lumen 152 that allows chyme to flow from thestomach 16 to thesmall intestine 18. Theneck portion 134 may be rigid to hold the pylorus 20 open or it may be compliant to allow the opening and closure of the throughlumen 152 with thepylorus 20. - In some embodiments, the
distal portion 132 is shaped in a circular or tubular shape. In some embodiments, thedistal portion 132 is shaped in a circular, disk, or tubular shape having a lip or rim. Thedistal portion 132 may interchangeably be referred to as a distal flange. The lip or rim may define a distal portionproximal end 144 and a distal portiondistal end 146. The lip or rim forming the distal portionproximal end 144 and the distal portiondistal end 146 may define an overall cylindrical or tubular shape. In some embodiments, thedistal portion 132 circular or disk shape defines a face orwall 150 also referred to herein as thedistal portion wall 150 or distal flange wall. Thedistal flange wall 150 may be located on the proximal side of thedistal flange 132. Thedistal flange wall 150 may be formed as a disk or disk shaped that is oriented transverse to the central axis. Theproximal end 144 of thedistal portion 132 may be connected to thedistal flange wall 150. In general, thedistal portion 132 or distal flange is located in the duodenum and thedistal flange 132 has an opening at thedistal end 146 that faces theintestine 18. - In some embodiments, the
distal flange 132, and theneck portion 134 each form a generally cylindrical shape, each with an independent diameter. For example, theproximal flange 130 has an overall cylindrical shape with an openproximal end 140 having a first diameter, and adistal end 142 having aproximal flange wall 148 that necks down to a diameter of theneck portion 134. Theproximal flange wall 148 can be shaped having an angle with a bias in relation to the central axis. Theneck portion 134 comprises a cylinder having a second diameter and extends between theproximal flange 130 and thedistal flange 132. Thedistal flange 132 has a generally cylindrical shape and includes thedistal flange wall 150 starting from theneck portion 134 and expanding radially from the central axis. Thedistal flange 132 has aproximal end 144 that is positioned near thepylorus 20, and adistal end 146 that faces into thesmall intestine 18. The anchor can be oriented by a central axis that is defined as the direction traveling from theproximal flange 130, through theneck portion 134, and continuing through thedistal flange 132. - The braided wire structure of the implant may be formed into a shape to promote anchoring to the tissue of a patient. For example, the
proximal flange wall 148 anddistal flange wall 150 can be angled in relation to theneck portion 134 in order to provide certain spatial relationships to the pylorus 20 at particular locations. In some embodiments, both theproximal flange 130 anddistal flange 132 are shaped to apply force F to the proximal and distal face of the pylorus 20, respectively. The effect of this force is intended to keep the implant in place, anchored across thepylorus 20. - The overall length of the
anchor 110 can be from about 10.0 mm to about 100.0 mm, but varying sized anchors may be formed, depending on a patient's anatomy or anatomical fit. In some embodiments, theanchor 110 length may be from about 10.0 mm to about 100 mm, from about 25.0 mm to about 75.0 mm, from about 40.0 mm to about 60.0 mm, or any length within these ranges. Anexemplary anchor 110 has been formed that is about 50.0 mm long but typical anchors may be in the range of between about 45.0 mm and 55.0 mm. In some embodiments, the diameter of theproximal flange 130 can be from about 10.0 mm to about 75.0 mm, or any range in between, for example from about 25.0 mm to about 60.0 mm, and from about 40.0 mm to about 55.0 mm. Anexemplary anchor 110 has been formed with the diameter of theproximal flange 130 about 40.0 mm. - In some embodiments, the
distal flange 132 is shaped as a cylinder with a generally opendistal end 146 and partially restrictedproximal end 144 connected to thedistal flange wall 150. Thedistal flange 132 may be formed in an overall cylindrical shape having a diameter. The length and diameter of thedistal flange 132 can be sized to prevent canting or tilting within a tubular anatomical structure such as the duodenum. In some embodiments, the diameter of thedistal flange 132 may be from about 5.00 mm to about 60.0 mm, or any range in between, for example from about 20.0 mm to about 50.0 mm, or from about 30.0 mm to about 40.0 mm. For example, the distal flange can have a length of roughly 18.0 mm and a diameter of 35.0 mm, to ensure the structure can remain positioned within a tubular anatomic structure such as the duodenal bulb with a diameter of about 40.0 mm. Anexemplary anchor 110 has been formed with the diameter of thedistal flange 132 about 35.0 mm in diameter. - As shown in
FIG. 3 , in some embodiments, the diameter of thedistal flange 132 may define a gap or space between the diameter of thedistal flange 132 and the duodenum. In some embodiments, a gap or space between the diameter of thedistal flange 132 and the duodenum may allow theanchor 110 to rotate or turn in a direction generally perpendicular to the central axis of theanchor 110 or a longitudinal axis defined by the center of the opening of the pylorus. If theanchor 110 is allowed to rotate after it is implanted in a patient, thedistal flange 132 oranchor 110 or both may undergo unwanted movement or deflection and in some cases become dislodged. Rotation or turning of theanchor 110 or thedistal flange 132 may be inhibited by providing adistal flange 132 having a suitable length and diameter. Adistal flange 132 length may allow thedistal flange 132 to contact the duodenum and prevent further rotation before thedistal flange 132 oranchor 110 become deflected or dislodged. The length of thedistal flange 132 may determine the degree of rotation theanchor 110 may undergo before contacting the duodenum. In some embodiments, the length and the diameter of thedistal flange 132 are sized such that upon rotation or canting of theanchor 110 away from the longitudinal axis, thedistal end 146 of thedistal flange 132 will make contact with the intestinal wall and therefore will resist migration of theanchor 110 within a patient. It has been found that a suitabledistal flange 132 length that may inhibit unwanted rotation or canting or longitudinal deflection may be from about 10.0 mm to about 50.0 mm or any length in between. In some embodiments, thedistal flange 132 may have a length that is sized in relation to the width of thedistal flange 132. - In some embodiments, the
distal flange 132 may have a length that is sized in relation to the length of theproximal flange 130. For example, the length of thedistal flange 132 may be the same length as theproximal flange 130. In some embodiments, the length of thedistal flange 132 may be multiples of the length of theproximal flange 130. For example, thedistal flange 132 may be one and a half, two times, three times, or greater, the length of theproximal flange 130. - In some embodiments, the diameter of the
neck portion 134 may be from about 2.0 mm to about 30.0 mm, or any range in between. for example from about 5.00 mm to about 30.0 mm, and from about 10.0 mm to about 20.0 mm. Anexemplary anchor 110 has been formed with the diameter of theneck portion 134 about 15.0 mm. - In some embodiments, the length of the
neck portion 134 may be approximately the width of a patient's pylorus. In some embodiments, the length of theneck portion 134 may be longer than the width of a patient's pylorus to provide a gap between theproximal flange wall 148 and thedistal flange wall 150 and thepylorus 20. In some embodiments, theneck portion 134 may be sized to allow theproximal flange wall 148 and thedistal flange wall 150 to contact thepylorus 20. In some embodiments, theanchor 110 is compressible in diameter and the overall diameter can be reduced to about 5.00 to 10.0 mm in diameter typically to allow theanchor 110 to be loaded into a catheter (described further below). - As shown in
FIG. 4 , in some embodiments, theanchor 110 is formed from a hollow tubular braidedstructure 160 of wire. The diameter of the wire that is used to form thebraided structure 160 can range from about 0.001 inch to about 0.014 inch, from about 0.004 inch to about 0.011 inch, from about 0.006 inch to about 0.009 or any diameter within this range such as 0.008 inch Thebraided structure 160 of wire is weaved to form amesh structure 162. Themesh structure 162 may be shaped to form the various elements of theanchor 110. Themesh structure 162 is formed into a shape with aproximal flange 130, aneck portion 134, and adistal flange 132. - The braided structure may be weaved to form a
mesh structure 162, and the mesh can be formed into various components. For example, themesh structure 162 may be formed into disks or cylinders of the various parts of theanchor 110. Suitably sized cylinders may be formed from the mesh structure and may have a diameter from about 10 mm in diameter to about 70 mm in diameter, from about 14 mm to about 50 mm in diameter, and any diameter in between. In some embodiments, abraided structure 160 of different diameters may be used at various locations of theanchor 110. For example, ananchor 110 may be created using abraided structure 160 having a diameter of about 14 mm for theneck portion 134, abraided structure 160 having a diameter of about 34 mm for thedistal flange 132, and abraided structure 160 having a diameter of about 40 mm for theproximal flange 130. In exemplary embodiments, the number of wire ends in thebraided structure 160 is 96 ends, but it can range from 4 ends to 256 ends. The wire can be formed from a metal such as Nitinol, MP35N, L605, Elgiloy, stainless steel or from a plastic such as Pet, Peek or Delrin or other suitable material. - The
anchor 110 can be covered on the outside and/or inside side with a polymer membrane covering. The membrane covering theanchor 110 may be made from a thin-walled polymer material such as silicone, polyurethane, polytetrafluoroethylene, fluorinated ethylene propylene, polyethylene, expanded poly tetrafluoroethylene (ePTFE) or other suitable material. In some embodiments, the wall thickness of the membrane covering theanchor 110 may be in the range of 0.001 inch to 0.030 inch thick. The membrane may be made by extrusion, dip coating from a liquid solution, powder coated from fine particles of polymer or paste extruded and then stretched as is the case with ePTFE. The anchor membrane may also be cut from a flat sheet of material such as ePTFE and then bonded or sewn into a disk shape or spherical shaped structure and then attached to theanchor 110 by sewing or gluing with a polymer such as FEP. - In some embodiments, the
anchor 110 also incorporates a structural element contained within the overall structure. Various configurations of the structural element can be found in the followingFIGS. 5 through 24 . -
FIG. 5 shows three views of the implant described inFIG. 3 and is intended to highlight an exemplary embodiment of ananchor 110 and astructural element 170. In some embodiments, astructural element 170 is located in any of theproximal flange 130, thedistal flange 132, or both. In an exemplary embodiment, astructural element 170 is located at least within thedistal flange 132. For example, astructural element 170 may be located in thedistal flange 132, proximate theneck portion 134, and may be weaved through themesh structure 162 to maintain a suitable position. Thestructural element 170 is typically designed to provide support to the braided structure and contribute to resisting compression or deformation of the overall shape of theanchor 110. Thebraided structure 160 alone will compress uniformly in response to a circumferential force and therefore the body may be able to push the implant from its location across the pylorus, leading to migration. With thestructural element 170 in place, the implant is more resistant to compression due to the shape and resistance of thestructural element 170. Thestructural element 170 may deform independently from thebraided structure 160 and therefore may provide support in addition to resistance to compression. Thestructural element 170 may provide support to the overall length, shape, diameter, or bias of theanchor 110. - The
structural element 170 can be made from a metal such as Nitinol, MP35N, L605, Elgiloy, stainless steel or from a plastic such as PET, PEEK, or Delrin or other suitable material. In a preferred embodiment, thestructural element 170 is made from superelastic Nitinol wire formed into the particular shape. The wire has a diameter from about 0.010 inch to about 0.030 inch, or from about 0.015 inch to about 0.025 inch, or any diameter in between. In one example, a structural element was formed from Nitinol wire having a diameter of about 0.020 inch in diameter. If a structural element having a particular rigidity or stiffness is required, often the size and material that the stiffening element is made from can be used to control these properties. As an example, Nitinol wire has been used to form stiffening elements, which have a compressive and expansive strength that is a function of the diameter of the wire used to make the stiffening element. - In some embodiments, the various components of the
anchor 110, including the braidedstructure 160, themesh structure 162, the mesh structure with a membrane, and thestructural element 170 provide structural support both individually and in combination. Thebraided structure 160 andmesh structure 162 may contribute support both in a radial and longitudinal direction. Thestructural element 170 may enhance the overall strength and rigidity of the anchor both in the radial and longitudinal direction. Additionally, thestructural element 170 may be tailored to provide a bias to thebraided structure 160 andmesh structure 162 to allow the anchor to form a particular shape in response to certain forces. For example, thestructural element 170 may add stiffness to theanchor 110 and allow it to maintain an effective circumference. Thestructural element 170 may provide a compression limit to theanchor 110. Thestructural element 170 may add longitudinal stability. Thestructural element 170 may inhibit theanchor 110 from moving through the pylorus. - As shown in
FIG. 5 , in some embodiments, thestructural element 170 is comprised in the shape of a ring. The diameter of a ring formed to create a structural element may be sized to form a suitable fit for use in ananchor 110, or at various locations on an anchor. For example, the diameter of a ring may be from about 20 mm to about 50 mm, from about 25 mm to about 45 mm, from about 30 mm to about 40 mm, and any diameter within this range. In one example, a ring was formed having a diameter of about 35 mm. -
FIG. 6 describes an alternative embodiment to the implant shown inFIG. 5 . In some embodiment, theanchor 110 incorporates a proximalstructural element 172. The proximalstructural element 172 is located at the proximal wall or face 148 of theproximal flange 130, nearest to theneck portion 134 of theanchor 110. The function of the proximalstructural element 172 is to resist compression of the overall structure. The proximalstructural element 172 is weaved through themesh structure 162 to secure it to theanchor 110. The proximal structural 172 element may be made from the same material as thestructural element 170. -
FIG. 7 is an alternative embodiment to the implant shown inFIG. 5 . Theanchor 110 incorporates twostructural elements distal flange 132. This configuration provides an additional option not available in the design shown inFIG. 5 by enabling the structure to be collapsed into a shape that can be loaded into a small diameter tube for the purpose of delivering or retrieving the implant endoscopically in a human. While thestructural elements structural elements structural elements -
FIG. 8 is an additional embodiment to the implant shown inFIG. 7 in which theanchor 110 incorporates threestructural elements structural elements distal flange 132. This configuration provides an advantage over the design shown inFIG. 7 because it is symmetrical with respect to thedistal flange 132 and with respect to a patient's anatomy. The overall structure can still be collapsed into a shape that can be loaded into a small diameter tube for the purpose of delivering or retrieving the implant endoscopically in a human. -
FIG. 9 illustrates an additional embodiment of an alternativestructural element 190. Theanchor 110 incorporates a single alternativestructural element 190 shaped to provide additional strength to the overall structure. This configuration provides an advantage over certain embodiments by enabling the structure to be collapsed more easily into a shape that can be loaded into a small diameter tube for the purpose of delivering or retrieving the implant endoscopically in a human. While the alternativestructural element 190 can still resist circumferential compression, when the structure is pulled into a tube, the alternativestructural element 190 will collapse into an elliptical shape. Various structural features also enable theanchor 110 containing an alternativestructural element 190 to be collapsed and provide a bias to the direction of collapse. -
FIG. 10 illustrates an additional embodiment of an alternativestructural element 190. Theanchor 110 incorporates an alternativestructural element 190 shaped to provide additional strength to the overall implant structure. This configuration enables the structure to be collapsed into a shape that can be loaded into a small diameter tube for the purpose of delivering or retrieving the implant endoscopically in a human. While the alternativestructural element 190 can still resist circumferential compression, when the structure is pulled into a tube, the alternativestructural element 190 will collapse into an elliptical shape. Various structural features also enable theanchor 110 containing an alternativestructural element 190 to be collapsed and provide a bias to the direction of collapse. -
FIGS. 11 to 20 illustrate various embodiments and shapes of an alternativestructural element 190. The embodiments shown inFIGS. 11 to 20 all have the features of providing additional strength to the overall structure of theanchor 110 and are collapsible. The illustrated embodiments enable theanchor 110 to be collapsed into a shape that can be loaded into a small diameter tube for the purpose of delivering or retrieving the implant endoscopically in a human. Various structural features also enable theanchor 110 containing an alternativestructural element 190 to be collapsed and provide a bias to the direction of collapse. - The
anchor 110 illustrated inFIGS. 9 to 24 has the advantage that astructural element 190 has been added to provide structural support to theanchor 110 in addition to thebraided structure 160. To provide structural support and to optimize the expanded configuration of either the proximal 130 flange, thedistal flange 132, or both flanges, the orientation of thestructural element 190 is arranged to provide any of a static radial force, a static longitudinal force, or both. As an example,FIG. 13 contains an embodiment of astructural element 190 that is capable of providing both radial support and longitudinal support. As used herein, the term longitudinal support refers to structural support for maintaining theanchor 110 in an expanded configuration along a direction parallel to the central axis. As used herein, the term radial support refers to support for maintaining theanchor 110 in an expanded configuration along a direction perpendicular to the central axis. Often this can be accomplished by having thestructural element 190 connected to the neck portion of theanchor 110 and transverse a flange in a radial direction. - In the structure illustrated in
FIG. 13 , thestructural element 190 is generally attached to theanchor 110 at various touch points. The shape and size of thestructural element 190 can be chosen to provide a suitable fit for a particular patient. It may be that certain portions of ananchor 110 require greater longitudinal support. This can be accomplished by increasing the size of thestructural element 190 in the longitudinal direction, as illustrated by comparing thestructural element 190 inFIGS. 11 to 13 . For example, in certain embodiments, a patient may need greater support in the longitudinal direction which can be accomplished by providing a compressive force by theanchor 110 in the longitudinal direction. Another option is to provide structural support in the longitudinal direction past the end of the distal flange. This may be accomplished by using the embodiment illustrated inFIG. 13 . - In some embodiments, the
structural element 190 illustrated inFIG. 13 may be used, for example, to maintain a sleeve that is attached to theanchor 110 in an open configuration. As an example, a sleeve may be attached to the neck portion of theanchor 110 at the distal wall. The sleeve may be attached to thestructural element 190 at various points along the sleeve as the sleeve extends through the end of the distal flange and continues out in a longitudinal direction. Thestructural element 190 is sized to extend past the end of the distal flange and thus a portion of thestructural element 190 can be attached to the sleeve outside the distal flange. In this configuration, the sleeve is held away from the neck portion at a greater distance and thus the sleeve is prevented from everting or inverting into the neck portion. This embodiment may provide a more versatile arrangement as well when attaching a wider sleeve in, for example, a patient with a wider intestine, thestructural element 190 can also be used to keep the sleeve open to allow food to enter the sleeve easier and continue on through the intestine. -
FIGS. 21 to 24 illustrate various embodiments and shapes of an alternativestructural element 190. The embodiments shown inFIGS. 21 to 24 all have the features of astructural element 190 providing additional strength to the overall structure of theanchor 110 and are collapsible. - In some embodiments, such as those shown in
FIGS. 21 to 24 , structural support can be provided to both the proximal flange and the distal flange with a singlestructural element 190 by providing astructural element 190 with a particular shape. For example, thestructural element 190 may be shaped with thestructural element 190 contoured through or oriented longitudinal to the neck portion and extending through at least one flange. The points of attachment on both the neck portion and the flanges are selected to enable compressive and expansive forces to be transferred between the flanges and the neck portion by thestructural element 190. - In the embodiments illustrated in
FIGS. 21 to 24 , thestructural element 190 traverses the neck portion of the anchor. The orientation and location of such astructural element 190 enables thestructural element 190 to maintain the angle of each flange perpendicular to the neck portion. This allows each flange to resist circumferential compression while also preventing each flange from canting. The illustrated embodiments enable theanchor 110 to be collapsed into a shape that can be loaded into a small diameter tube for the purpose of delivering or retrieving the implant endoscopically in a human. Various structural features also enable theanchor 110 containing an alternativestructural element 190 to be collapsed and provide a bias to the direction of collapse. - As shown in
FIG. 25 , in some embodiments, theanchor 110 has a distal structural element comprised of threerings distal flange 132. The distalstructural element structural element - The distal
structural element structural element structural element structural element - As shown in
FIGS. 25 and 26 , the three rings of the distalstructural element distal flange 132 and are attached to thedistal flange 132 by being integrally woven into the flange material. The rings of the distalstructural element distal flange 132 and then the wire ends are inserted into a sleeve and crimped or welded.FIG. 26 contains a side view of an example embodiment of theanchor 110, illustrating how each ring may be arranged with at least a portion of each ring attached to the distal flangedistal end 146 and a portion attached to the distal flangedistal wall 150. In still further embodiments, each ring may be attached with at least a portion of each ring closer to the distal flangeproximal end 144 and a portion attached to the distal flangedistal wall 150. - To provide structural support and to optimize the expansive force of the flanges, the orientation of the structural element or rings are arranged to provide any of a static radial force, a static longitudinal force or both. Often this requires the structural element to receive radial support from the neck portion or the wall of the anchor. In some embodiments, such as those shown in
FIGS. 21 to 24 , this is accomplished by providing a structural element with a particular shape. In some embodiments, the design of the structural element may incorporate a plurality of rings. The orientation of the rings relative to the wall or face of the flange can be designed to provide suitable static structure. This can be accomplished by placing the rings out-of-plane with the flange wall. In a structure incorporating rings for the structural element, the rings are generally attached to the implant at about four locations. The attachment locations are evenly spaced around the ring and enable the compressive and expansive forces to be transferred between the flanges and the structural element evenly. - As shown in
FIGS. 25 and 26 , in some embodiments theanchor 110 may have a proximalstructural element 172 attached to theproximal flange 130. The proximalstructural element 172 may also be referred to as a compression bias spring. The proximalstructural element 172 may be constructed as a substantially circularframe having nodes 204. The proximalstructural element 172 may be constructed from the same material that forms the distalstructural element structural element 172 may also provide structural support to theproximal flange 130. For example, the proximalstructural element 172 generally has an overall frame that is compressible, yet also is rigid. The rigid proximalstructural element 172 tends to impart additional strength to theproximal flange 130 and aids in keeping theproximal end 140 of theproximal flange 130 open. The proximalstructural element 172 can be shaped to bias the collapse of the diameter of theanchor 110 for removal from a patient and for loading the device onto a delivery catheter for delivery within a patient. - As shown in
FIGS. 25 and 26 in some embodiments, theanchor 110 may include adrawstring 192. The drawstring may be attached to theproximal flange 130. Thedrawstring 192 typically can be attached to theproximal flange 130 by weaving thedrawstring 192 through the material of theproximal flange 130. As shown inFIG. 26 , the drawstring may be weaved through the material of the proximal flange and have a portion of the drawstring forming adrawstring loop 205. For example, thedrawstring 192 may be constructed from a string or suture that is weaved through alternating cells in the braided wire structure of theanchor 110. Thedraw string loop 205 allows thedrawstring 192 to be attached to a retraction tool, for example by a hook or a clamp. In some embodiments, thedrawstring 192 is simply a suture that is weaved through theproximal flange 130. The drawstring may be separate from the proximalstructural element 172. The drawstring may be constructed from any range of suture material and may comprise a thin wire or cable. Thedrawstring 192 can be used to elastically contract theanchor 110 by connecting at least oneloop 205 to a removal device (not shown) and by drawing into a sheath, for example a catheter. In some embodiments, thedrawstring 192 allows theproximal flange 130 to collapse to the diameter of theneck portion 134. -
FIG. 27 shows theanchor 110 from an axial perspective looking down the longitudinal direction from thedistal end 146 of thedistal flange 132. In some embodiments, thedistal flange 132 has anouter circumference 198, defined by the outer most edge of theproximal end 144 ordistal end 146 of thedistal flange 132, and aninner circumference 199 defined by the location where the distal flangedistal wall 150 meets theneck portion 134. In some embodiments, theinner circumference 199 of the distal flange is the same circumference as a circumference of theneck portion 134. As illustrated inFIG. 27 , the distalstructural element distal flange 132 to provide pressure outward from aninner circumference 199, for example starting from the distal flangedistal wall 150, and push outward against theouter circumference 198 of thedistal flange 132. -
FIG. 28 illustrates the proximalstructural element 172 and thedrawstring 192 within theproximal flange 130 of theanchor 110 as viewed from an axial perspective looking down the longitudinal direction from theproximal end 140 of theproximal flange 130. In some embodiments, theproximal flange 130 has anouter circumference 208, defined by the outer most edge of theproximal end 140 ordistal end 142 of theproximal flange 130, and an inner circumference 209 defined by the location where the proximal flangeproximal wall 148 meets the neck portion 134 (shown inFIG. 26 ). In some embodiments, the inner circumference 209 of theproximal flange 130 is the same as a circumference of theneck portion 134. -
FIG. 29 illustrates an embodiment of the proximalstructural element 172 without the anchor, to illustrate an overall shape and structure.FIG. 29 shows the proximalstructural element 172 as viewed from an axial perspective looking down the longitudinal direction and shows the proximalstructural element 172 having amain body 212 that is substantially circular and having adiameter 214. The proximalstructural element diameter 214 may be in the range of from 1.0 inch to 2.0 inches, and any range in between such as from about 1.3 inches to about 1.8 inches, or from about 1.5 inches to about 1.7 inches. In an example embodiment, the proximal structural elementmain body 212 comprised a ring having a diameter of about 1.57 inches, or about 40.0 mm. - The proximal
structural element 172 may be formed of material having a thickness in the range from 0.015 inch to about 0.045 inch, or any range within such as from about 0.020 inch to about 0.035 inch, from about 0.025 inch to about 0.030 inch. In an example embodiment, a proximalstructural element 172 was formed from material having a thickness of about 0.025 inch, or about 0.64 mm. - In some embodiments, attached to the
main body 212 of the proximalstructural element 172 is a plurality ofnodes 204. As shown inFIGS. 30A and 30B , when viewed from the side, the proximal structural elementmain body 212 has an overall planar structure, with thenodes 204 extending from the plane of themain body 212. The nodes may be at anangle 214 to the plane of themain body 212, for example thenodes 204 may be formed to extend at a 60 degree angle from themain body 212. Thenodes 204 may each have anouter loop 213 and aninner curve 215. Theouter loop 213 allows a bias for the proximalstructural element 172 to collapse radially in response to a compressive force. This action can be desirable for removal of the anchor from a patient and for loading the implant onto a delivery catheter for delivery within a patient. Additionally, theangle 214 helps to collapse the anchor in a uniform manner when the drawstring is pulled. Theangle 214 of eachnode 204 allows for evenly distributed tension to be imparted to themain body 212 without forming a pinch point. Theangle 214 also forms a shape that allows the anchor a bias toward a retracted configuration when tension is placed on thedrawstring 172. - In some embodiments, the
anchor 110 may be may be configured to collapse into a narrower size. For example, theanchor 110 may be collapsed into a narrower diameter for placement or removal from a patient.FIG. 31 shows theproximal flange 130 of theanchor 110 in the collapsed stage. In some embodiments the anchor can be collapsed by pulling the drawstring. Thedrawstring node 205 may be pulled away from theanchor 110, collapsing the proximalstructural element 172.FIG. 31 shows theproximal flange 130 in a collapsed stage after thedrawstring 192 has been pulled. - As shown in
FIG. 32 , in some embodiments, theproximal flange wall 148 and thedistal flange wall 150 may be constructed with a bias in relation to the central axis. Thestructural element 170 may also be configured to impart a bias on thedistal flange wall 150. The proximal structural element, (not shown) may also impart a similar bias on theproximal flange wall 148. For example, thestructural element 170 may be configured to impart a bias against thedistal flange wall 150 in the proximal direction. For example, the distalstructural element 170 may be configured to impart a bias against thedistal flange wall 150 in the proximal direction. In other words, in some embodiments, theproximal flange wall 148 and thedistal flange wall 150 may not be a completely flat configuration, but instead may have an angle, curve, or slope. As also shown inFIG. 32 , the neck portion of the anchor has alength 216. In some embodiments, because of the slope, curve, or angle, of theproximal flange wall 148 anddistal flange wall 150 thedistance 218 between the outer circumference (208 inFIG. 28 ) of theproximal flange wall 148 and the outer circumference (198 inFIG. 27 ) of thedistal flange wall 150 may be less than the length of theneck portion 216. As a result, theproximal flange wall 148 has aproximal gap 200 and the distal flange wall has adistal gap 202. Theproximal gap 200 is defined by the difference in the longitudinal location of theproximal flange wall 148 at the outer circumference (208 inFIG. 28 ) and the inner circumference (209 inFIG. 28 ). Thedistal gap 202 is defined by the difference in the longitudinal location of thedistal flange wall 150 at the outer circumference (198 inFIG. 27 ) and the inner circumference (199 inFIG. 27 ). -
FIGS. 33 and 34 show anexemplary sleeve 120 that may be used in conjunction with an anchor. As shown previously inFIG. 2 , thesleeve 120 may be attached to theanchor 110 and be placed within thesmall intestine 18. In various exemplary embodiments, thesleeve 120 is integrally formed with or coupled to theanchor 110. According to some embodiments, thesleeve 120 is removably or releasably coupled to theanchor 110. - As shown in
FIG. 34 , an overall schematic of a sleeve according to some embodiments includes amouth 220, asleeve body 222, and aneck 224 Thesleeve body 222 diameter is generally sized to match the diameter of the human small intestine. The diameter decreases at theneck 224 to be consistent with the inner diameter of the anchor. This change in diameter also helps to prevent sleeve eversion in which the sleeve folds back into itself in response to an increase in pressure on the outside of the sleeve. According to various embodiments, the sleeve body has a thickness of between about 0.001 and about 0.015 inches. Thesleeve neck 224 is intended to be thicker than thesleeve body 222, for example 0.005 inches versus 0.001 inches thick, to provide a second mechanism to prevent sleeve eversion. When the sleeve is subjected to an external pressure, thethicker neck 224 collapses and does not fold back on itself. This mechanism essentially creates a duck-bill valve. - The
sleeve 120 can vary in length from 1.0-2.0 inches in length up to several feet. In some embodiments, thesleeve 120 bypasses the length of the duodenum up to the ligament of treitz. While various embodiments disclosed herein describe theintestinal bypass sleeve 120 as extending into the duodenum, in all such embodiments, it is also contemplated that theintestinal bypass sleeve 120 has a length sufficient to allow it to extend partially or fully into the jejunum. Often the length of the sleeve is dictated by the required mechanism of action. It has been shown that an effective sleeve length is one that allows it to reach the proximal jejunum; this location corresponds to the location of the ligament of Trietz. The length of the sleeve is determined based on the desired clinical outcome. Recent scientific research has indicated that a sleeve roughly 2 feet in length is sufficient to modify the transport and absorption of food and organ secretions within the small intestine, leading to remission of type 2 diabetes. - The
intestinal bypass sleeve 120 may be made from a thin-walled polymer material such as silicone, polyurethane, polytetrafluoroethylene, fluorinated ethylene propylene, polyethylene, expanded polytetrafluoroethylene (ePTFE) or other suitable material. In exemplary embodiments, the wall thickness of theintestinal bypass sleeve 120 may be between 0.0006 inch and 0.010 inch thick. Theintestinal bypass sleeve 120 may be made by extrusion, into a tubular form or a lay flat tubing, dip coated from a liquid solution, powder coated from fine particles of polymer or paste extruded and then stretched as is the case with ePTFE. - The gastrointestinal device thus described comprises an anchor configured to be implanted and remain within a pylorus of a patient. The gastrointestinal device may comprise an anchor having a flexible thin-walled sleeve attached to the distal end of the anchor. In some embodiments, secondary anchors may also anchor other portions of the thin-walled sleeve. The anchor may be placed within a pylorus of a patient to assist in opening a pylorus of the patient. The sleeve may be placed within the intestine of the patient and held in place by the anchor. The device thus described may function as follows.
- As a person ingests food, the food enters the mouth, is chewed, and then proceeds down the esophagus and into the stomach. The food mixes with enzymes in the mouth and in the stomach. The stomach converts the food to a semi-fluid substance called chyme. The chyme enters the pyloric antrum and exits the stomach through the pylorus. The pylorus (or pyloric sphincter) is a band of muscle that functions to adjust the diameter of the pyloric orifice, which in turn effects the rate at which chyme exits the stomach. The pylorus (or phyloric sphincter or pyloric wall) also has a width (or thickness), which is the distance that the pylorus extends between the stomach and the duodenum.
- A gastrointestinal implant placed within the pylorus of a patent can be employed to control the opening and closing of the pylorus to control the flow rate of chyme from the stomach to the intestine of the patient. An exemplary gastrointestinal implant has been formed that can assume both an expanded and contracted configuration. In an exemplary configuration, the implant has a neck portion that allows chyme to flow from the stomach to the intestine of a patient. The width of the neck portion can be designed to control the flow rate of chyme from the stomach to the intestine. The flow rate of chyme can optionally be modified depending on the suitable blood glucose levels of the patient.
- The gastrointestinal implant may be held in place within a pylorus of a patient by using an anchor. The anchor comprises a proximal flange and a distal flange connected to the neck portion to anchor the neck portion in place. The proximal flange is configured to remain on the stomach side of a patient's pylorus and the distal flange is configured to remain on the intestinal side of a patient's pylorus. The widths of the proximal flange and distal flange in the expanded configuration are wider than the maximum diameter of the pylorus.
- The length of the neck portion can be configured to provide an optimum fit within the pylorus of a patient while preventing the neck portion from agitating the tissue of the pylorus. It has been discovered that an optimum length of the neck portion reduces agitation of the tissue of the pylorus by the anchor by reducing contact between the proximal and distal flanges of the anchor and the pyloric wall. By creating the neck portion to be longer than the width of the pyloric wall, the proximal flange and distal flange are arranged such that they have minimal contact with the pylorus as the pylorus opens and closes. Additionally or alternatively, the shape of the proximal flange and distal flange can be formed to include a bias that reduces contact with the pylorus as the pylorus opens and closes. For example, the proximal flange and distal flange may be formed to provide a space between the proximal flange and distal flange and the pylorus.
- The anchor may be formed from material having a hollow tubular braided structure that can assume a collapsed configuration for placement within and removal from a patient's digestive system. The hollow tubular braided structure also can assume an expanded configuration for suitable placement within a patient's digestive track. The anchor may include a structural element that provides additional structural support to the anchor and keeps the anchor in an expanded configuration yet also allows the anchor to be compressed for ease of placement within and extraction from a patient. For example, a structural element can be placed within the distal flange to provide structural support in the radial direction and thus prevent the distal flange from reverting into the stomach of a patient. Additionally or alternatively, a drawstring may be placed within the proximal flange to provide structural support in the radial direction and prevent the proximal flange from traveling into the intestine of a patient. Both the structural elements can be configured to be compressed into a collapsed configuration to allow the anchor to be placed within and removed from within a patient's digestive track. The neck portion of the anchor can be tailored to span the pylorus, and may be tailored to fit various patients of various dimensions. Additionally, the length of the neck portion can be tailored to extend past the pylorus to reduce a compressive force exerted by the flanges onto the pylorus. For example, the length of the neck portion can be designed to sit within the patient's anatomy without continuous contact with the walls of the duodenal bulb and pyloric antrum. The diameter of the neck portion can also be sized to allow food to pass from a patient's stomach to intestine yet remain narrow enough to prevent it from propping open the pylorus.
- The small intestine is about 21 feet long in adults. The small intestine is comprised of three sections: the duodenum, jejunum , and ileum. The duodenum is the first portion of the small intestine and is typically 10.0 -12.0 inches long. The duodenum is comprised of four sections: the superior, descending, horizontal and ascending. The duodenum ends at the ligament of treitz. The duodenal bulb is the portion of the duodenum which is closest to the stomach. Suitably designed sleeves can be sized wherein the length of the sleeve determines at what point the chyme is allowed to contact the intestine. The design and length of the sleeve also determines at what point food that is traveling through the sleeve comes into contact with digestive juices.
- The gastrointestinal implant described here in can be placed within a patient's digestive track by inserting an endoscope through the mouth, esophagus and stomach to the pylorus. An over-the-wire sizing balloon is inserted through the working channel of the endoscope over a guidewire and is advanced across the pyloric opening. The balloon is inflated with saline or contrast media to a low pressure to open the pylorus and duodenum and allow measurement of the lumen diameter of the pyloric antrum, pylorus and duodenal bulb.
- In some embodiments, blood glucose levels can be measured by a glucose sensor and the insulin infusion rates and optimum chyme flow rates can be set by the diameter of the neck portion. Currently diabetic patients monitor blood glucose levels and then based on their insulin levels inject themselves with insulin either with a syringe or with an infusion pump. Gastric emptying rates vary depending upon the composition of the food eaten. Sugars pass quickly from the stomach into the small intestine and protein and fats move from the stomach into the small intestine more slowly. Blood sugar control can be difficult to manage if the flow rate of chyme from the stomach to the small intestine is unpredictable and in the case of patients with gastroparesis the chyme flow rate can be very slow to zero. The disclosure herein described will allow for a tighter glucose level control by allowing more precise control of the flow rate of chyme into small intestine and modulating the flow rate of chyme base on blood glucose levels and insulin infusion rate.
- Various modifications and additions can be made to the exemplary embodiments discussed without departing from the scope of the present invention. For example, while the embodiments described above refer to particular features, the scope of this invention also includes embodiments having different combinations of features and embodiments that do not include all of the above described features.
Claims (20)
1. A gastrointestinal implant for use within a pylorus of a patient, the gastrointestinal implant comprising:
an anchor having an expanded configuration, a contracted configuration, and a longitudinal axis, and comprising:
a proximal portion including a hollow tubular braided structure of wire defining
a first cylinder having a proximal end, a distal end, and a first wall extending from the proximal end to the distal end, and
a second wall extending radially inward from the distal end of the proximal portion traverse to the longitudinal axis, the second wall having an outer diameter and a first opening defining an inner diameter;
a neck portion comprising a second cylinder having a proximal end, a distal end, and a third wall extending from the proximal end to the distal end, the proximal end of the neck portion attached to the first opening of the second wall; and
a distal portion comprising a hollow tubular braided structure of wire defining
a third cylinder having a proximal end, a distal end, a fourth wall extending between the proximal end and the distal end, and
a fifth wall extending radially inward from the distal portion of the proximal end, the fifth wall having an outer diameter and a second opening attached to the distal end of the neck portion, the second opening defining an inner diameter; and
a structural element having a first section attached to the proximal portion of the anchor and a second section attached to the distal portion of the anchor, the structural element configured to resist circumferential compression of the proximal and distal portion relative to the longitudinal axis.
2. The gastrointestinal implant of claim 1 , wherein the structural element further comprises a third section attached to the neck portion.
3. The gastrointestinal implant of claim 1 , wherein the structural element is attached to the first wall, second wall, third wall, fourth wall, and fifth wall of the anchor.
4. The gastrointestinal implant of claim 1 , wherein the structural element is configured to resist canting of the proximal portion and the distal portion with respect to the longitudinal axis.
5. The gastrointestinal implant of claim 1 , wherein the structural element is configured to resist rotation of the proximal and distal portion relative to the longitudinal axis.
6. The gastrointestinal implant of claim 1 , wherein the structural element is configured to maintain the first and second cylinder parallel to the longitudinal axis.
7. The gastrointestinal implant of claim 1 , wherein the structural element is configured to maintain the second wall and the fifth wall perpendicular to the longitudinal axis.
8. The gastrointestinal implant of claim 1 , wherein the structural element is configured to transfer at least one of compressive and expansive forces between the proximal and distal portions.
9. A gastrointestinal implant for use within a pylorus of a patient, the gastrointestinal implant comprising:
an anchor transitionable between an expanded configuration and a contracted configuration, the anchor having a longitudinal axis and comprising:
a proximal portion including a hollow tubular braided structure of wire defining a first cylinder and having a proximal end, a distal end, a first wall extending from the proximal end to the distal end, and a second wall extending radially inward from the distal end of the proximal portion traverse to the longitudinal axis, the second wall having an outer diameter and a first opening defining an inner diameter of the second wall;
a neck portion comprising a second cylinder having a proximal end, a distal end, and a third wall extending from the proximal end to the distal end, the proximal end of the neck portion attached to the first opening of the second wall; and
a distal portion comprising a hollow tubular braided structure of wire defining a third cylinder and having a proximal end, a distal end, a fourth wall extending between the proximal end and the distal end, and a fifth wall extending radially inward from the distal portion proximal end, the fifth wall having an outer diameter and a second opening attached to the distal end of the neck portion, the second opening defining an inner diameter of the fifth wall; and
a structural element having a first section attached to the proximal portion of the anchor and a second section attached to the distal portion of the anchor, the structural element configured to resist rotation of the proximal and distal portion relative to the longitudinal axis.
10. The gastrointestinal implant of claim 9 , wherein the structural element is attached to the proximal portion, the neck portion, and the distal portion of the anchor, such that the structural element transfers compressive and expansive forces between the proximal portion and distal portion of the anchor.
11. The gastrointestinal implant of claim 9 , wherein the structural element has a first section extended along the second wall and a second section extended along the fifth wall, the first and second section of the structural element oriented in a direction transverse to the longitudinal axis.
12. The gastrointestinal implant of claim 9 , wherein the structural element is configured to resist rotation of the proximal and distal portion relative to one another.
13. The gastrointestinal implant of claim 9 , wherein the structural element is configured to bias the anchor in a direction of collapse.
14. A gastrointestinal implant for use within a pylorus, a duodenal bulb, and a duodenum of a patient, the implant having an expanded configuration and a contracted configuration and comprising:
an anchor having a longitudinal axis and including:
a proximal portion including a hollow tubular braided structure of wire and defining a cylinder having a proximal end, a distal end, and a first wall extending radially inward from the distal end of the proximal portion, wherein the first wall has an outer circumference and a first opening defining an inner circumference;
a neck portion including a cylinder having a proximal end attached to the first opening, a distal end, and a neck wall extending from the proximal end to the distal end;
a distal portion including a hollow tubular braided structure of wire and defining a cylinder having a proximal end, a distal end, an outer wall extending between the proximal end and the distal end, and a second wall extending radially inward from the proximal end of the distal portion, wherein the second wall has an outer circumference and a second opening defining an inner circumference and attached to the distal end of the neck portion; and
a plurality of rings attached to the distal portion, wherein each ring of the plurality of rings has a first section attached to the outer wall of the distal portion and a second section attached to at least one of the second wall and the neck portion, and wherein each ring of the plurality of rings is oriented in a plane, the plurality of rings configured to resist compression of the distal portion in a direction transverse to the longitudinal axis.
15. The gastrointestinal implant of claim 14 , wherein the first section of each ring of the plurality of rings is attached along a circumference of the outer wall and the second section of each ring of the plurality of rings is attached along a circumference of at least one of the second wall and the neck portion.
16. The gastrointestinal implant of claim 14 , wherein each ring of the plurality of rings has a round shape, a rectangular shape, a square shape or an elliptical shape.
17. The gastrointestinal implant of claim 14 , wherein the first wall defines a concave surface that is curved between the outer circumference and the inner circumference of the first wall.
18. The gastrointestinal implant of claim 14 , wherein the first wall defines a concave surface that is curved between the outer circumference of the first wall and the proximal end of the neck portion with a curve perpendicular to the longitudinal axis.
19. The gastrointestinal implant of claim 14 , wherein the second wall defines a concave surface that is curved between the outer circumference and the inner circumference of the second wall.
20. The gastrointestinal implant of claim 14 , wherein the second wall defines a concave surface that is curved between the outer circumference of the second wall and the distal end of the neck portion with a curve perpendicular to the longitudinal axis.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/983,530 US20200360167A1 (en) | 2016-03-03 | 2020-08-03 | Pyloric anchors and methods for intestinal bypass sleeves |
US18/606,266 US20240261126A1 (en) | 2016-03-03 | 2024-03-15 | Pyloric anchors and methods for intestinal bypass sleeves |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/060,418 US9622897B1 (en) | 2016-03-03 | 2016-03-03 | Pyloric anchors and methods for intestinal bypass sleeves |
US15/489,444 US10729573B2 (en) | 2016-03-03 | 2017-04-17 | Pyloric anchors and methods for intestinal bypass sleeves |
US16/983,530 US20200360167A1 (en) | 2016-03-03 | 2020-08-03 | Pyloric anchors and methods for intestinal bypass sleeves |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/489,444 Continuation US10729573B2 (en) | 2016-03-03 | 2017-04-17 | Pyloric anchors and methods for intestinal bypass sleeves |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US18/606,266 Continuation US20240261126A1 (en) | 2016-03-03 | 2024-03-15 | Pyloric anchors and methods for intestinal bypass sleeves |
Publications (1)
Publication Number | Publication Date |
---|---|
US20200360167A1 true US20200360167A1 (en) | 2020-11-19 |
Family
ID=58765402
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/060,418 Active US9622897B1 (en) | 2016-03-03 | 2016-03-03 | Pyloric anchors and methods for intestinal bypass sleeves |
US15/489,444 Active 2036-08-14 US10729573B2 (en) | 2016-03-03 | 2017-04-17 | Pyloric anchors and methods for intestinal bypass sleeves |
US16/983,530 Abandoned US20200360167A1 (en) | 2016-03-03 | 2020-08-03 | Pyloric anchors and methods for intestinal bypass sleeves |
US18/606,266 Pending US20240261126A1 (en) | 2016-03-03 | 2024-03-15 | Pyloric anchors and methods for intestinal bypass sleeves |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/060,418 Active US9622897B1 (en) | 2016-03-03 | 2016-03-03 | Pyloric anchors and methods for intestinal bypass sleeves |
US15/489,444 Active 2036-08-14 US10729573B2 (en) | 2016-03-03 | 2017-04-17 | Pyloric anchors and methods for intestinal bypass sleeves |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US18/606,266 Pending US20240261126A1 (en) | 2016-03-03 | 2024-03-15 | Pyloric anchors and methods for intestinal bypass sleeves |
Country Status (4)
Country | Link |
---|---|
US (4) | US9622897B1 (en) |
EP (2) | EP3423128B1 (en) |
ES (1) | ES2905050T3 (en) |
WO (1) | WO2017151951A1 (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010093603A1 (en) | 2009-02-11 | 2010-08-19 | Boston Scientific Scimed, Inc. | Insulated ablation catheter devices and methods of use |
US10159699B2 (en) | 2013-01-15 | 2018-12-25 | Metamodix, Inc. | System and method for affecting intestinal microbial flora |
JP2017529169A (en) | 2014-10-13 | 2017-10-05 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Tissue diagnosis and treatment using mini-electrodes |
US9622897B1 (en) | 2016-03-03 | 2017-04-18 | Metamodix, Inc. | Pyloric anchors and methods for intestinal bypass sleeves |
EP3457998A4 (en) | 2016-05-19 | 2020-07-29 | Metamodix, Inc. | Pyloric anchor retrieval tools and methods |
WO2020264526A1 (en) * | 2019-06-28 | 2020-12-30 | Ganz Alexander S | Obesity treatment devices, systems, and methods |
US20200222221A1 (en) * | 2017-07-21 | 2020-07-16 | Gi Dynamics, Inc. | Gastrointestinal device delivery systems and methods of use thereof |
EP3752105A1 (en) | 2018-02-12 | 2020-12-23 | Biomedix SA | Therapeutic-gard and method of use thereof |
US10869670B2 (en) * | 2018-03-26 | 2020-12-22 | Olympus Corporation | Procedure for endoscopic full-thickness resection |
EP3773249A1 (en) | 2018-03-29 | 2021-02-17 | Boston Scientific Scimed Inc. | Devices and systems for pyloric occlusion |
PL3777784T3 (en) * | 2018-04-12 | 2023-02-06 | Hangzhou Tangji Medical Technology Co., Ltd. | Gastric diverter and digestive tract support and release method thereof |
CN113164271A (en) | 2018-09-24 | 2021-07-23 | 波士顿科学国际有限公司 | Repositionable and removable bracket |
EP3914200A1 (en) * | 2019-01-22 | 2021-12-01 | Lean Medical Technologies, Inc. | Obesity treatment device and method |
CA3217104A1 (en) * | 2021-04-28 | 2022-11-03 | Kedar R. Belhe | Systems and method for stabilizing anti-migration anchor system |
CN117769404A (en) * | 2021-05-10 | 2024-03-26 | 波士顿科学国际有限公司 | Devices, systems, and methods for occluding an anatomic passageway |
EP4115855A1 (en) * | 2021-07-09 | 2023-01-11 | BariaTek Medical | Pyloric anchor and gastro-intestinal tube |
CN118234456A (en) * | 2021-11-15 | 2024-06-21 | 波士顿科学国际有限公司 | Devices, systems, and methods for pyloric occlusion |
Family Cites Families (256)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4315509A (en) | 1977-01-10 | 1982-02-16 | Smit Julie A | Insertion and removal catheters and intestinal tubes for restricting absorption |
US4134405A (en) | 1977-01-10 | 1979-01-16 | Smit Julie A | Catheter and intestine tube and method of using the same |
WO1980000007A1 (en) | 1978-06-02 | 1980-01-10 | A Rockey | Medical sleeve |
US4246893A (en) | 1978-07-05 | 1981-01-27 | Daniel Berson | Inflatable gastric device for treating obesity |
US4204530A (en) | 1979-03-29 | 1980-05-27 | Medical Engineering Corp. | Sleeve implant |
US4314405A (en) | 1980-04-24 | 1982-02-09 | Park Du P | Hair cutting device |
US4899747A (en) | 1981-12-10 | 1990-02-13 | Garren Lloyd R | Method and appartus for treating obesity |
US4416267A (en) | 1981-12-10 | 1983-11-22 | Garren Lloyd R | Method and apparatus for treating obesity |
US4719916A (en) | 1983-10-03 | 1988-01-19 | Biagio Ravo | Intraintestinal bypass tube |
US4905693A (en) | 1983-10-03 | 1990-03-06 | Biagio Ravo | Surgical method for using an intraintestinal bypass graft |
US4763653A (en) | 1985-02-19 | 1988-08-16 | Rockey Arthur G | Medical sleeve |
US4716900A (en) | 1986-05-09 | 1988-01-05 | Pfizer Hospital Products Group, Inc. | Intraintestinal bypass graft |
US5234454A (en) | 1991-08-05 | 1993-08-10 | Akron City Hospital | Percutaneous intragastric balloon catheter and method for controlling body weight therewith |
FR2688401B1 (en) | 1992-03-12 | 1998-02-27 | Thierry Richard | EXPANDABLE STENT FOR HUMAN OR ANIMAL TUBULAR MEMBER, AND IMPLEMENTATION TOOL. |
US5322697A (en) | 1992-05-28 | 1994-06-21 | Meyer James H | Composition and method for inducing satiety |
IT1260485B (en) | 1992-05-29 | 1996-04-09 | PROCEDURE AND DEVICE FOR THE TREATMENT OF THE OBESITY OF A PATIENT | |
US5246456A (en) | 1992-06-08 | 1993-09-21 | Wilkinson Lawrence H | Fenestrated gastric pouch |
US5306300A (en) | 1992-09-22 | 1994-04-26 | Berry H Lee | Tubular digestive screen |
US5474563A (en) | 1993-03-25 | 1995-12-12 | Myler; Richard | Cardiovascular stent and retrieval apparatus |
US5480423A (en) | 1993-05-20 | 1996-01-02 | Boston Scientific Corporation | Prosthesis delivery |
US5824040A (en) | 1995-12-01 | 1998-10-20 | Medtronic, Inc. | Endoluminal prostheses and therapies for highly variable body lumens |
US5749921A (en) | 1996-02-20 | 1998-05-12 | Medtronic, Inc. | Apparatus and methods for compression of endoluminal prostheses |
DE29708149U1 (en) | 1997-05-07 | 1997-09-25 | Binmöller, Kenneth F., Dr., 20251 Hamburg | Biopsy device |
US6017563A (en) | 1997-07-25 | 2000-01-25 | Novus International, Inc. | Process for optimizing milk production |
US5820584A (en) | 1997-08-28 | 1998-10-13 | Crabb; Jerry A. | Duodenal insert and method of use |
US6224627B1 (en) | 1998-06-15 | 2001-05-01 | Gore Enterprise Holdings, Inc. | Remotely removable covering and support |
US6746489B2 (en) | 1998-08-31 | 2004-06-08 | Wilson-Cook Medical Incorporated | Prosthesis having a sleeve valve |
US7118600B2 (en) | 1998-08-31 | 2006-10-10 | Wilson-Cook Medical, Inc. | Prosthesis having a sleeve valve |
US20080086214A1 (en) | 1998-08-31 | 2008-04-10 | Wilson-Cook Medical Inc. | Medical device having a sleeve valve with bioactive agent |
IL129032A (en) | 1999-03-17 | 2006-12-31 | Moshe Dudai | Gastric band |
US7160312B2 (en) | 1999-06-25 | 2007-01-09 | Usgi Medical, Inc. | Implantable artificial partition and methods of use |
US6454699B1 (en) | 2000-02-11 | 2002-09-24 | Obtech Medical Ag | Food intake restriction with controlled wireless energy supply |
US6790210B1 (en) | 2000-02-16 | 2004-09-14 | Trans1, Inc. | Methods and apparatus for forming curved axial bores through spinal vertebrae |
AU4729201A (en) | 2000-03-06 | 2001-09-17 | Us Surgical | Apparatus and method for performing a bypass procedure in a digestive system |
FR2808674B1 (en) | 2000-05-12 | 2002-08-02 | Cie Euro Etude Rech Paroscopie | GASTROPLASTY RING WITH GRIPPED LEGS |
US6540789B1 (en) | 2000-06-15 | 2003-04-01 | Scimed Life Systems, Inc. | Method for treating morbid obesity |
DE60143801D1 (en) | 2000-08-11 | 2011-02-17 | Univ Temple | TREATMENT OF GRAVITY |
US6368617B1 (en) | 2001-05-15 | 2002-04-09 | Reliv' International, Inc. | Dietary supplement |
DE10158785B8 (en) | 2001-05-27 | 2012-01-05 | Marc O. Schurr | Medical implant |
WO2002096325A1 (en) | 2001-05-27 | 2002-12-05 | Schurr Marc O | Medical implant |
US7083629B2 (en) | 2001-05-30 | 2006-08-01 | Satiety, Inc. | Overtube apparatus for insertion into a body |
US6558400B2 (en) | 2001-05-30 | 2003-05-06 | Satiety, Inc. | Obesity treatment tools and methods |
US6821291B2 (en) | 2001-06-01 | 2004-11-23 | Ams Research Corporation | Retrievable stent and method of use thereof |
US20020188354A1 (en) | 2001-06-12 | 2002-12-12 | Peghini Paolo Lino | Device to treat obesity by obstructing gastric outlet |
CN101810521B (en) | 2001-08-27 | 2015-05-13 | 辛尼科有限责任公司 | Satiation devices and methods |
US6845776B2 (en) | 2001-08-27 | 2005-01-25 | Richard S. Stack | Satiation devices and methods |
US6675809B2 (en) | 2001-08-27 | 2004-01-13 | Richard S. Stack | Satiation devices and methods |
US7097665B2 (en) | 2003-01-16 | 2006-08-29 | Synecor, Llc | Positioning tools and methods for implanting medical devices |
US20040117031A1 (en) | 2001-08-27 | 2004-06-17 | Stack Richard S. | Satiation devices and methods |
US20030060842A1 (en) | 2001-09-27 | 2003-03-27 | Yem Chin | Method and apparatus for measuring and controlling blade depth of a tissue cutting apparatus in an endoscopic catheter |
US6740121B2 (en) | 2001-11-09 | 2004-05-25 | Boston Scientific Corporation | Intragastric stent for duodenum bypass |
US6755869B2 (en) | 2001-11-09 | 2004-06-29 | Boston Scientific Corporation | Intragastric prosthesis for the treatment of morbid obesity |
US7335210B2 (en) | 2002-04-03 | 2008-02-26 | Julie Ann Smit | Endoscope and tools for applying sealants and adhesives and intestinal lining for reducing food absorption |
US7146984B2 (en) | 2002-04-08 | 2006-12-12 | Synecor, Llc | Method and apparatus for modifying the exit orifice of a satiation pouch |
JP4426852B2 (en) | 2002-04-08 | 2010-03-03 | シネコー・エルエルシー | Saturation device and method |
JP4347705B2 (en) | 2002-04-09 | 2009-10-21 | ファン キム,ジェ | Medical intestinal tract manager for stool bypass of patients with bowel surgery |
WO2003094785A1 (en) | 2002-05-09 | 2003-11-20 | Egan Thomas D | Gastric bypass prosthesis |
US20040019388A1 (en) | 2002-07-24 | 2004-01-29 | Starkebaum Warren L. | Methods and implants for retarding stomach emptying to treat eating disorders |
AU2003263816A1 (en) | 2002-07-26 | 2004-02-16 | Transneuronix, Inc. | Improved process for electrostimulation treatment of morbid obesity |
US6746460B2 (en) | 2002-08-07 | 2004-06-08 | Satiety, Inc. | Intra-gastric fastening devices |
US7211114B2 (en) | 2002-08-26 | 2007-05-01 | The Trustees Of Columbia University In The City Of New York | Endoscopic gastric bypass |
US7214233B2 (en) | 2002-08-30 | 2007-05-08 | Satiety, Inc. | Methods and devices for maintaining a space occupying device in a relatively fixed location within a stomach |
US7229428B2 (en) | 2002-10-23 | 2007-06-12 | Satiety, Inc. | Method and device for use in endoscopic organ procedures |
US7220237B2 (en) | 2002-10-23 | 2007-05-22 | Satiety, Inc. | Method and device for use in endoscopic organ procedures |
US7037344B2 (en) | 2002-11-01 | 2006-05-02 | Valentx, Inc. | Apparatus and methods for treatment of morbid obesity |
EP1555970B1 (en) | 2002-11-01 | 2014-09-24 | Valentx, Inc. | Apparatus for treatment of morbid obesity |
US9060844B2 (en) | 2002-11-01 | 2015-06-23 | Valentx, Inc. | Apparatus and methods for treatment of morbid obesity |
US20090149871A9 (en) | 2002-11-01 | 2009-06-11 | Jonathan Kagan | Devices and methods for treating morbid obesity |
US8070743B2 (en) | 2002-11-01 | 2011-12-06 | Valentx, Inc. | Devices and methods for attaching an endolumenal gastrointestinal implant |
US7837669B2 (en) | 2002-11-01 | 2010-11-23 | Valentx, Inc. | Devices and methods for endolumenal gastrointestinal bypass |
US7794447B2 (en) | 2002-11-01 | 2010-09-14 | Valentx, Inc. | Gastrointestinal sleeve device and methods for treatment of morbid obesity |
US6656194B1 (en) | 2002-11-05 | 2003-12-02 | Satiety, Inc. | Magnetic anchoring devices |
US20040133147A1 (en) | 2002-11-06 | 2004-07-08 | Woo Sang Hoon | Intestinal bypass device to treat obesity |
US7163554B2 (en) | 2002-11-15 | 2007-01-16 | Synecor, Llc | Endoprostheses and methods of manufacture |
US7608114B2 (en) | 2002-12-02 | 2009-10-27 | Gi Dynamics, Inc. | Bariatric sleeve |
BR0316956A (en) | 2002-12-02 | 2005-10-25 | Gi Dynamics Inc | Gastrointestinal implant device; treatment method; method of treating type 2 diabetes; delivery system for placing a gastrointestinal implant device in a body; removal device for removing a gastrointestinal implant device from the body; and delivery appliance |
US7678068B2 (en) | 2002-12-02 | 2010-03-16 | Gi Dynamics, Inc. | Atraumatic delivery devices |
US7695446B2 (en) | 2002-12-02 | 2010-04-13 | Gi Dynamics, Inc. | Methods of treatment using a bariatric sleeve |
US20070032879A1 (en) | 2002-12-02 | 2007-02-08 | Levine Andy H | Anti-buckling sleeve |
US7766973B2 (en) | 2005-01-19 | 2010-08-03 | Gi Dynamics, Inc. | Eversion resistant sleeves |
US7025791B2 (en) | 2002-12-02 | 2006-04-11 | Gi Dynamics, Inc. | Bariatric sleeve |
US7037343B2 (en) | 2002-12-23 | 2006-05-02 | Python, Inc. | Stomach prosthesis |
US20040143342A1 (en) | 2003-01-16 | 2004-07-22 | Stack Richard S. | Satiation pouches and methods of use |
US7618435B2 (en) | 2003-03-04 | 2009-11-17 | Nmt Medical, Inc. | Magnetic attachment systems |
US7291160B2 (en) | 2003-03-17 | 2007-11-06 | Delegge Rebecca | Intragastric catheter |
ATE422858T1 (en) | 2003-03-28 | 2009-03-15 | Gi Dynamics Inc | ANTI-OBESITY DEVICES |
EP1610719B1 (en) | 2003-03-28 | 2010-01-13 | GI Dynamics, Inc. | Sleeve for delayed introduction of enzymes into the intestine |
US7175638B2 (en) | 2003-04-16 | 2007-02-13 | Satiety, Inc. | Method and devices for modifying the function of a body organ |
US20040267291A1 (en) | 2003-06-27 | 2004-12-30 | Byrum Randal T. | Implantable band with non-mechanical attachment mechanism |
US20090259236A2 (en) | 2003-07-28 | 2009-10-15 | Baronova, Inc. | Gastric retaining devices and methods |
US6994095B2 (en) | 2003-07-28 | 2006-02-07 | Medventure Associates Iv | Pyloric valve corking device and method |
US8048169B2 (en) | 2003-07-28 | 2011-11-01 | Baronova, Inc. | Pyloric valve obstructing devices and methods |
US9498366B2 (en) | 2003-07-28 | 2016-11-22 | Baronova, Inc. | Devices and methods for pyloric anchoring |
US9700450B2 (en) | 2003-07-28 | 2017-07-11 | Baronova, Inc. | Devices and methods for gastrointestinal stimulation |
US8308765B2 (en) | 2004-05-07 | 2012-11-13 | Usgi Medical, Inc. | Apparatus and methods for positioning and securing anchors |
US7314489B2 (en) | 2003-08-20 | 2008-01-01 | Ethicon Endo-Surgery, Inc. | Method and apparatus to facilitate nutritional malabsorption |
US7608086B2 (en) | 2003-09-30 | 2009-10-27 | Ethicon Endo-Surgery, Inc. | Anastomosis wire ring device |
US20050247320A1 (en) | 2003-10-10 | 2005-11-10 | Stack Richard S | Devices and methods for retaining a gastro-esophageal implant |
US8206456B2 (en) | 2003-10-10 | 2012-06-26 | Barosense, Inc. | Restrictive and/or obstructive implant system for inducing weight loss |
US20050080444A1 (en) | 2003-10-14 | 2005-04-14 | Kraemer Stefan J.M. | Transesophageal gastric reduction device, system and method |
EP1696806B1 (en) | 2003-11-21 | 2012-08-29 | Silk Road Medical, Inc. | Apparatus for treating a carotid artery |
US20060212042A1 (en) | 2005-03-17 | 2006-09-21 | Lamport Ronald B | Removal and repositioning device |
JP4512597B2 (en) | 2003-12-09 | 2010-07-28 | ジーアイ・ダイナミックス・インコーポレーテッド | Device fixed in gastrointestinal tract and fixing method |
US8057420B2 (en) | 2003-12-09 | 2011-11-15 | Gi Dynamics, Inc. | Gastrointestinal implant with drawstring |
JP2007514482A (en) | 2003-12-12 | 2007-06-07 | シネコー・エルエルシー | Implantable medical device having a preimplantation exoskeleton |
US7594885B2 (en) | 2004-02-20 | 2009-09-29 | Ethicon Endo-Surgery, Inc. | Method for implanting an adjustable band |
US20070265709A1 (en) | 2004-02-25 | 2007-11-15 | Mayo Foundatio For Medical Education And Research | Gastric Bypass Devices and Methods |
US8585771B2 (en) | 2004-02-26 | 2013-11-19 | Endosphere, Inc. | Methods and devices to curb appetite and/or to reduce food intake |
US7931693B2 (en) | 2004-02-26 | 2011-04-26 | Endosphere, Inc. | Method and apparatus for reducing obesity |
US8147561B2 (en) | 2004-02-26 | 2012-04-03 | Endosphere, Inc. | Methods and devices to curb appetite and/or reduce food intake |
US20050197714A1 (en) | 2004-03-02 | 2005-09-08 | Sayet Peter H. | System, system devices, and methods for regulating nutrient absorption and caloric intake |
DE102004011764A1 (en) | 2004-03-09 | 2005-09-29 | Novineon Healthcare Technology Partners Gmbh | Medical implant |
AU2005231323B2 (en) | 2004-03-26 | 2011-03-31 | Ethicon Endo-Surgery, Inc | Systems and methods for treating obesity |
US8425539B2 (en) | 2004-04-12 | 2013-04-23 | Xlumena, Inc. | Luminal structure anchoring devices and methods |
US20050228413A1 (en) | 2004-04-12 | 2005-10-13 | Binmoeller Kenneth F | Automated transluminal tissue targeting and anchoring devices and methods |
US7507218B2 (en) | 2004-04-26 | 2009-03-24 | Gyrus Acmi, Inc. | Stent with flexible elements |
US20050246037A1 (en) | 2004-04-30 | 2005-11-03 | Medtronic, Inc. | Partial esophageal obstruction to limit food intake for treatment of obesity |
US7520884B2 (en) | 2004-05-07 | 2009-04-21 | Usgi Medical Inc. | Methods for performing gastroplasty |
EP1750591B1 (en) | 2004-05-07 | 2021-03-24 | USGI Medical Inc | Anchor for implantation in a body |
US20080262529A1 (en) | 2004-05-14 | 2008-10-23 | C.R. Bard, Inc. | Gastric Balloon Devices and Methods of Use |
US7909839B2 (en) | 2004-05-26 | 2011-03-22 | Bariatec Corporation | Gastric bypass band and surgical method |
EP1750755A1 (en) | 2004-06-02 | 2007-02-14 | Technion Research And Development Foundation, Ltd. | Methods and formulations for increasing intestinal function |
US7803195B2 (en) | 2004-06-03 | 2010-09-28 | Mayo Foundation For Medical Education And Research | Obesity treatment and device |
US20050288555A1 (en) | 2004-06-28 | 2005-12-29 | Binmoeller Kenneth E | Methods and devices for illuminating, vievwing and monitoring a body cavity |
WO2006014496A2 (en) | 2004-07-06 | 2006-02-09 | Amrish Walke | Obesity treatment devices |
JP4856067B2 (en) | 2004-07-09 | 2012-01-18 | ジーアイ・ダイナミックス・インコーポレーテッド | Method and apparatus for positioning a gastrointestinal sleeve |
US20060020277A1 (en) | 2004-07-20 | 2006-01-26 | Gostout Christopher J | Gastric reshaping devices and methods |
US20060036267A1 (en) | 2004-08-11 | 2006-02-16 | Usgi Medical Inc. | Methods and apparatus for performing malabsorptive bypass procedures within a patient's gastro-intestinal lumen |
EP1778069A4 (en) | 2004-08-17 | 2009-12-02 | Kenneth Binmoeller | Sterile endoscopic instrument housing |
JP2008514244A (en) | 2004-09-07 | 2008-05-08 | ビンモエラー,ケネス | Endoscopic device having independently operated legs |
US7261725B2 (en) | 2005-01-13 | 2007-08-28 | Binmoeller Kenneth F | Endoscopic device with independently actuated legs |
EP1799145B1 (en) | 2004-09-17 | 2016-12-21 | GI Dynamics, Inc. | Gastrointestinal anchor |
US20060155375A1 (en) | 2004-09-27 | 2006-07-13 | Jonathan Kagan | Devices and methods for attachment of a gastrointestinal sleeve |
EP3511047B1 (en) | 2004-12-08 | 2024-03-13 | Boston Scientific Scimed, Inc. | Apparatus for performing needle guided interventions |
US20080140172A1 (en) | 2004-12-13 | 2008-06-12 | Robert Hunt Carpenter | Multi-Wall Expandable Device Capable Of Drug Delivery Related Applications |
US7771382B2 (en) | 2005-01-19 | 2010-08-10 | Gi Dynamics, Inc. | Resistive anti-obesity devices |
US7658196B2 (en) | 2005-02-24 | 2010-02-09 | Ethicon Endo-Surgery, Inc. | System and method for determining implanted device orientation |
US7699863B2 (en) | 2005-03-01 | 2010-04-20 | Tulip Medical Ltd. | Bioerodible self-deployable intragastric implants |
EP1863405A2 (en) | 2005-03-18 | 2007-12-12 | Thomas D. Egan | Gastric bypass prosthesis fixation system and method for treatment of obesity |
US20060258906A1 (en) | 2005-05-16 | 2006-11-16 | Binmoeller Kenneth F | Systems and methods to facilitate endoscopic |
US8425535B2 (en) | 2005-05-20 | 2013-04-23 | Neotract, Inc. | Multi-actuating trigger anchor delivery system |
JP5269589B2 (en) | 2005-05-23 | 2013-08-21 | シネコー・エルエルシー | Restricted and / or occluded implant system for promoting weight loss |
US7976488B2 (en) | 2005-06-08 | 2011-07-12 | Gi Dynamics, Inc. | Gastrointestinal anchor compliance |
US8784437B2 (en) | 2005-06-09 | 2014-07-22 | Xlumena, Inc. | Methods and devices for endosonography-guided fundoplexy |
US8777967B2 (en) | 2005-06-09 | 2014-07-15 | Xlumena, Inc. | Methods and devices for anchoring to tissue |
US7364542B2 (en) | 2005-07-15 | 2008-04-29 | Ethicon Endo-Surgery, Inc. | Gastric band suture tab extender |
US7367937B2 (en) | 2005-07-15 | 2008-05-06 | Ethicon Endo-Surgey, Inc. | Gastric band |
US7871416B2 (en) | 2005-07-22 | 2011-01-18 | Phillips Edward H | Clamp device to plicate the stomach |
US7779845B2 (en) | 2005-08-05 | 2010-08-24 | Ethicon Endo-Surgery, Inc. | Method and apparatus for endoscopically performing gastric reduction surgery |
US8029522B2 (en) | 2005-08-05 | 2011-10-04 | Ethicon Endo-Surgery, Inc. | Method and apparatus for sealing a gastric opening |
US7896894B2 (en) | 2005-08-05 | 2011-03-01 | Ethicon Endo-Surgery, Inc. | Apparatus for single pass gastric restriction |
WO2007030829A2 (en) | 2005-09-09 | 2007-03-15 | Biomedix, S.A. | Medical device and method for controlling obesity |
EP1937164A1 (en) | 2005-09-27 | 2008-07-02 | Synecor, LLC | Transgastric surgical devices and procedures |
US9055942B2 (en) | 2005-10-03 | 2015-06-16 | Boston Scienctific Scimed, Inc. | Endoscopic plication devices and methods |
ATE468817T1 (en) | 2005-10-03 | 2010-06-15 | Barosense Inc | ENDOSCOPIC FOLDING DEVICES |
US20080221597A1 (en) | 2005-10-12 | 2008-09-11 | Wallace Jeffrey M | Methods and devices for intragastrointestinal fixation |
US8038720B2 (en) | 2005-10-18 | 2011-10-18 | Wallace Jeffrey M | Methods and devices for intragastrointestinal prostheses |
US20070100367A1 (en) | 2005-10-31 | 2007-05-03 | Quijano Rodolfo C | Intragastric space filler |
US20070239284A1 (en) | 2005-12-22 | 2007-10-11 | Skerven Gregory J | Coiled intragastric member for treating obesity |
JP5329236B2 (en) | 2006-02-03 | 2013-10-30 | バロノヴァ,インク. | Gastrointestinal apparatus and method for treating addiction |
EP1832250A1 (en) | 2006-03-11 | 2007-09-12 | Dr. Karel Volenec - ELLA - CS | Stent extractor |
US20070213751A1 (en) | 2006-03-13 | 2007-09-13 | Scirica Paul A | Transdermal magnetic coupling gastric banding |
US20090118749A1 (en) | 2006-03-20 | 2009-05-07 | Svip 2 Llc | Pyloric Devices and Methods |
WO2007136468A2 (en) | 2006-04-07 | 2007-11-29 | Valentx, Inc. | Devices and methods for endolumenal gastrointestinal bypass |
US7833156B2 (en) | 2006-04-24 | 2010-11-16 | Transenterix, Inc. | Procedural cannula and support system for surgical procedures |
US7881797B2 (en) | 2006-04-25 | 2011-02-01 | Valentx, Inc. | Methods and devices for gastrointestinal stimulation |
US9060835B2 (en) | 2006-05-26 | 2015-06-23 | Endosphere, Inc. | Conformationally-stabilized intraluminal device for medical applications |
WO2007139920A2 (en) | 2006-05-26 | 2007-12-06 | Endosphere, Inc. | Improvements in methods and devices to curb appetite and/or reduce food intake |
US7922684B2 (en) | 2006-05-30 | 2011-04-12 | Boston Scientific Scimed, Inc. | Anti-obesity dual stent |
US20070282418A1 (en) | 2006-05-30 | 2007-12-06 | Boston Scientific Scimed, Inc. | Anti-obesity flow controller |
US7867283B2 (en) | 2006-05-30 | 2011-01-11 | Boston Scientific Scimed, Inc. | Anti-obesity diverter structure |
US8002731B2 (en) | 2006-05-30 | 2011-08-23 | Boston Scientific Scimed, Inc. | Anti-obesity stent |
WO2007145684A2 (en) | 2006-06-08 | 2007-12-21 | Xlumena, Inc. | Methods and devices for anchoring to soft tissue |
US7819836B2 (en) | 2006-06-23 | 2010-10-26 | Gi Dynamics, Inc. | Resistive anti-obesity devices |
US20090299486A1 (en) | 2006-06-29 | 2009-12-03 | Slimedics Ltd. | Gastrointestinal Prostheses |
WO2008005510A2 (en) | 2006-07-06 | 2008-01-10 | Synecor, Llc | Systems and methods for restoring function of diseased bowel |
US20080065136A1 (en) | 2006-08-30 | 2008-03-13 | Andrew Young | Distender device and method for treatment of obesity and metabolic and other diseases |
US20080161935A1 (en) | 2006-09-01 | 2008-07-03 | Albrecht Thomas E | Method for inducting weight loss using a coil for insertion into a hollow body organ |
ES2527923T3 (en) | 2006-09-02 | 2015-02-02 | Barosense, Inc. | Intestinal sleeves and associated deployment systems and methods |
EP2068719B1 (en) | 2006-09-15 | 2017-10-25 | Boston Scientific Scimed, Inc. | System for anchoring stomach implant |
WO2008039800A2 (en) | 2006-09-25 | 2008-04-03 | Valentx, Inc. | Toposcopic access and delivery devices |
US7892220B2 (en) | 2006-10-04 | 2011-02-22 | Ethicon Endo-Surgery, Inc. | Use of an adhesive as an intestinal barrier for bariatrics |
US20080092910A1 (en) | 2006-10-18 | 2008-04-24 | Allergan, Inc. | Apparatus and method for treating obesity using neurotoxins in conjunction with bariatric procedures |
US8105392B2 (en) * | 2006-11-08 | 2012-01-31 | Boston Scientific Scimed, Inc. | Pyloric obesity valve |
US8628553B2 (en) | 2006-11-08 | 2014-01-14 | Ethicon Endo-Surgery, Inc. | Expanding adhesive foam structure to reduce stomach volume |
US20080255476A1 (en) | 2006-11-20 | 2008-10-16 | Tom Boyajian | Methods and devices for treating obesity |
WO2008076383A2 (en) | 2006-12-18 | 2008-06-26 | Med Institute Inc. | Stent graft with releasable therapeutic agent |
US8529431B2 (en) | 2007-02-14 | 2013-09-10 | Bfkw, Llc | Bariatric device and method |
EP2117640B1 (en) | 2007-02-14 | 2019-04-17 | Bfkw, Llc | Bariatric device |
US8801647B2 (en) | 2007-02-22 | 2014-08-12 | Gi Dynamics, Inc. | Use of a gastrointestinal sleeve to treat bariatric surgery fistulas and leaks |
US8460314B2 (en) | 2007-02-26 | 2013-06-11 | Olympus Medical Systems Corp. | Application of procedure through natural orifice |
US20080208239A1 (en) | 2007-02-27 | 2008-08-28 | Gary Annunziata | Method for treating obesity using an implantable weight loss device |
WO2008106041A1 (en) | 2007-02-27 | 2008-09-04 | Agt, Inc. | Implantable weight control device |
US10238518B2 (en) | 2007-02-27 | 2019-03-26 | Agt Inc. | Implantable weight control device |
EP2332473A1 (en) | 2007-02-28 | 2011-06-15 | Wilson-Cook Medical INC. | Intestinal bypass using magnets |
WO2008109527A2 (en) | 2007-03-02 | 2008-09-12 | Wilson-Cook Medical Inc. | Apparatus and methods for delaying gastric emptying to treat obesity |
US8979872B2 (en) | 2007-03-13 | 2015-03-17 | Longevity Surgical, Inc. | Devices for engaging, approximating and fastening tissue |
WO2008112942A2 (en) | 2007-03-13 | 2008-09-18 | Harris Peter S | Methods and devices for reducing gastric volume |
US20080249635A1 (en) | 2007-04-05 | 2008-10-09 | Barry Weitzner | Gastric filler devices for obesity therapy |
US20080255678A1 (en) | 2007-04-13 | 2008-10-16 | Cully Edward H | Medical apparatus and method of making the same |
US9717584B2 (en) | 2007-04-13 | 2017-08-01 | W. L. Gore & Associates, Inc. | Medical apparatus and method of making the same |
US9642693B2 (en) | 2007-04-13 | 2017-05-09 | W. L. Gore & Associates, Inc. | Medical apparatus and method of making the same |
US20080294179A1 (en) | 2007-05-12 | 2008-11-27 | Balbierz Daniel J | Devices and methods for stomach partitioning |
US8485964B2 (en) | 2007-05-15 | 2013-07-16 | Ethicon Endo-Surgery, Inc. | Gastric band with supply tube check valve |
DK1992351T3 (en) | 2007-05-18 | 2016-06-06 | Nestec Sa | Lactobacillus johnsonii for the prevention of post-surgical infection |
US8506516B2 (en) | 2007-05-29 | 2013-08-13 | Cvdevices, Llc | Devices, systems, and methods for achieving magnetic gastric bypass |
US20090012544A1 (en) | 2007-06-08 | 2009-01-08 | Valen Tx, Inc. | Gastrointestinal bypass sleeve as an adjunct to bariatric surgery |
WO2008154450A1 (en) | 2007-06-08 | 2008-12-18 | Valentx, Inc. | Methods and devices for intragastric support of functional or prosthetic gastrointestinal devices |
WO2008154594A2 (en) | 2007-06-11 | 2008-12-18 | Valentx, Inc. | Endoscopic delivery devices and methods |
US20080312559A1 (en) | 2007-06-12 | 2008-12-18 | Santilli Albert N | Method and Apparatus for Performing Gastric Bypass Surgery |
WO2009005625A1 (en) | 2007-07-03 | 2009-01-08 | Synecor, Llc | Satiation devices and methods for controlling obesity |
CA2693259C (en) | 2007-07-16 | 2018-04-17 | Kenneth F. Binmoeller | A conformationally-stabilized intraluminal device for medical applications |
CN101827559B (en) | 2007-07-18 | 2013-05-29 | 压力感应器公司 | Endoscopic implant system |
WO2009011881A1 (en) | 2007-07-18 | 2009-01-22 | Barosense, Inc. | Overtube introducer for use in endoscopic bariatric surgery |
AU2008296110B2 (en) | 2007-09-07 | 2013-03-14 | Baronova, Inc. | Device for intermittently obstructing a gastric opening and method of use |
EP2194917B1 (en) | 2007-09-12 | 2018-08-22 | Ballast Medical Inc. | Devices for treatment of obesity |
US8052745B2 (en) | 2007-09-13 | 2011-11-08 | Boston Scientific Scimed, Inc. | Endoprosthesis |
US20090093767A1 (en) | 2007-10-04 | 2009-04-09 | Brian Kelleher | Devices and methods for endolumenal therapy |
WO2009055362A1 (en) | 2007-10-26 | 2009-04-30 | Moore Brenda E | Probiotic compositions and methods for inducing and supporting weight loss |
US9492149B2 (en) | 2007-11-13 | 2016-11-15 | Cook Biotech Incorporated | Fistula grafts and related methods and systems useful for treating gastrointestinal and other fistulae |
US20090182355A1 (en) | 2007-12-20 | 2009-07-16 | Levine Andy H | Porous barbs for long-term anchoring in the gastrointestinal tract |
AU2008340270A1 (en) | 2007-12-21 | 2009-07-02 | Medical And Surgical Review, P.C. | Methods and devices for endoscopically creating an anastomosis |
US7883524B2 (en) | 2007-12-21 | 2011-02-08 | Wilson-Cook Medical Inc. | Method of delivering an intragastric device for treating obesity |
US20090171383A1 (en) | 2007-12-31 | 2009-07-02 | David Cole | Gastric space occupier systems and methods of use |
WO2009097585A1 (en) | 2008-02-01 | 2009-08-06 | Endometabolic Solutions, Inc. | Methods and devices for performing gastroplasty |
EP2240092A4 (en) | 2008-02-01 | 2015-05-06 | Medical And Surgical Review P C | Methods and devices for anchoring a gastroenterologic sleeve |
US8100850B2 (en) | 2008-04-09 | 2012-01-24 | E2 Llc | Pyloric valve devices and methods |
US10350050B2 (en) | 2008-05-01 | 2019-07-16 | Ethicon Endo-Surgery, Inc. | Method for gastric volume reduction surgery |
US20090281379A1 (en) | 2008-05-12 | 2009-11-12 | Xlumena, Inc. | System and method for transluminal access |
US8236022B2 (en) | 2008-06-27 | 2012-08-07 | Ethicon Endo-Surgery, Inc. | Implantable device for the treatment of obesity |
US8092479B2 (en) | 2008-06-27 | 2012-01-10 | Ethicon Endo-Surgery, Inc. | Implantable device for the treatment of obesity |
US9173760B2 (en) | 2009-04-03 | 2015-11-03 | Metamodix, Inc. | Delivery devices and methods for gastrointestinal implants |
BRPI1014701B8 (en) | 2009-04-03 | 2021-06-22 | Metamodix Inc | modular system to treat metabolic disorders such as diabetes and obesity |
US8702641B2 (en) | 2009-04-03 | 2014-04-22 | Metamodix, Inc. | Gastrointestinal prostheses having partial bypass configurations |
AU2014200766B2 (en) | 2009-04-03 | 2015-06-25 | Metamodix, Inc. | Modular gastrointestinal prostheses |
US20120065571A1 (en) | 2009-04-03 | 2012-03-15 | Metamodix, Inc. | Expandable pyloric anchors and methods for securing intestinal bypass sleeves |
US9278019B2 (en) | 2009-04-03 | 2016-03-08 | Metamodix, Inc | Anchors and methods for intestinal bypass sleeves |
US8403877B2 (en) | 2009-07-01 | 2013-03-26 | E2 Llc | Systems and methods for treatment of obesity and type 2 diabetes |
US20110104327A1 (en) | 2009-04-23 | 2011-05-05 | Bacterfield International S.A. | Probiotic pet food |
US8183441B2 (en) | 2009-05-14 | 2012-05-22 | Monsanto Technology Llc | Plants and seeds of hybrid corn variety CH413233 |
US20100305590A1 (en) | 2009-05-29 | 2010-12-02 | Gi Dynamics, Inc. | Transpyloric Anchoring |
US8574184B2 (en) | 2009-07-01 | 2013-11-05 | E2 Llc | Systems and methods for treatment of obesity and type 2 diabetes |
IN2012DN00316A (en) | 2009-07-10 | 2015-05-08 | Metamodix Inc | |
US20140194806A1 (en) | 2009-07-10 | 2014-07-10 | Metamodix, Inc. | External anchoring configurations for modular gastrointestinal prostheses |
WO2011073970A1 (en) | 2009-12-18 | 2011-06-23 | Vysera Biomedical Limited | A gastrointestinal implant device |
WO2011099940A1 (en) | 2010-02-11 | 2011-08-18 | National University Of Singapore | System, device, and process for modifying absorption of matter by a gastrointestinal wall |
WO2011116025A1 (en) | 2010-03-15 | 2011-09-22 | Innovelle, Llc | Bariatric device and method for weight loss |
US9220499B2 (en) | 2010-10-28 | 2015-12-29 | Covidien Lp | Wound closure device including barbed pins |
AU2012211067B2 (en) | 2011-01-28 | 2016-07-21 | Metamodix, Inc. | Anchors and methods for intestinal bypass sleeves |
US8888732B2 (en) | 2011-03-11 | 2014-11-18 | Apollo Endosurgery, Inc. | Intraluminal sleeve with active agents |
US10195066B2 (en) * | 2011-12-19 | 2019-02-05 | Coloplast A/S | Luminal prosthesis and implant device |
US9451960B2 (en) | 2012-05-31 | 2016-09-27 | Valentx, Inc. | Devices and methods for gastrointestinal bypass |
US10159699B2 (en) | 2013-01-15 | 2018-12-25 | Metamodix, Inc. | System and method for affecting intestinal microbial flora |
WO2015138465A1 (en) | 2014-03-10 | 2015-09-17 | Metamodix, Inc. | External anchoring configurations for modular gastrointestinal prostheses |
US9913744B2 (en) * | 2014-04-30 | 2018-03-13 | Lean Medical Technologies, Inc. | Gastrointestinal device |
US9622897B1 (en) | 2016-03-03 | 2017-04-18 | Metamodix, Inc. | Pyloric anchors and methods for intestinal bypass sleeves |
-
2016
- 2016-03-03 US US15/060,418 patent/US9622897B1/en active Active
-
2017
- 2017-03-02 WO PCT/US2017/020494 patent/WO2017151951A1/en active Application Filing
- 2017-03-02 EP EP17760842.9A patent/EP3423128B1/en active Active
- 2017-03-02 EP EP21183837.0A patent/EP3973929A1/en not_active Withdrawn
- 2017-03-02 ES ES17760842T patent/ES2905050T3/en active Active
- 2017-04-17 US US15/489,444 patent/US10729573B2/en active Active
-
2020
- 2020-08-03 US US16/983,530 patent/US20200360167A1/en not_active Abandoned
-
2024
- 2024-03-15 US US18/606,266 patent/US20240261126A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP3423128B1 (en) | 2021-11-03 |
WO2017151951A1 (en) | 2017-09-08 |
US20240261126A1 (en) | 2024-08-08 |
US9622897B1 (en) | 2017-04-18 |
EP3973929A1 (en) | 2022-03-30 |
EP3423128A1 (en) | 2019-01-09 |
EP3423128A4 (en) | 2020-01-01 |
US10729573B2 (en) | 2020-08-04 |
ES2905050T3 (en) | 2022-04-06 |
US20170252195A1 (en) | 2017-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20240261126A1 (en) | Pyloric anchors and methods for intestinal bypass sleeves | |
US9044300B2 (en) | Gastrointestinal prostheses | |
EP2451411B1 (en) | External anchoring configurations for modular gastrointestinal prostheses | |
JP4980569B2 (en) | Gastrointestinal implant device and delivery system for placing the device in the body | |
AU2014200766B2 (en) | Modular gastrointestinal prostheses | |
US20120065571A1 (en) | Expandable pyloric anchors and methods for securing intestinal bypass sleeves | |
US20050080491A1 (en) | Bariatric sleeve delivery devices | |
US20140194806A1 (en) | External anchoring configurations for modular gastrointestinal prostheses | |
EP1708641A1 (en) | Intestinal sleeve | |
WO2015138465A1 (en) | External anchoring configurations for modular gastrointestinal prostheses | |
CN114585332A (en) | Barrier device, system and method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |